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ABSTRACT 
 
Cloprostenol, a prostaglandin F2α analogue, is commonly used for reproductive work in 
equine practice. Its main indications in equine reproduction are termination of the luteal 
phase and early pregnancy, evacuation of uterine fluid and induction of parturition. 
However, cloprostenol may be responsible for several other biological reproductive 
effects than the main indications of its use, which may influence the reproductive 
outcome and management of the mare. Moreover, these proposed side effects include 
advancement of ovulation, enhancement of follicular development, an increase in 
multiple ovulation rate and ovulatory failure in cyclic mares and a reduction in fertility. 
The objective of this study was largely the characterization of these side effects 
observed in a clinical setting of equine practice and to determine their impact on the 
reproductive management of mares.  
 
Records from clinical observations of ovarian and uterine ultrasonography, treatment 
protocols and reproductive management of mares were obtained from two types of 
settings: a commercial Thoroughbred stud farm and a veterinary clinic. These data were 
analyzed retrospectively to determine and characterize some of the side effects of 
cloprostenol associated with its clinical use in inducing oestrus in mares. 
 
Mares which ovulated spontaneously had similar preovulatory follicular diameters in 
two consecutive cycles. However, when the consecutive oestrus was induced by 
cloprostenol, the follicular diameter decreased significantly, which was probably due to 
an enhanced follicular maturation rate. Treatment of dioestrous mares with cloprostenol, 
who had relatively large follicles resulted in higher uterine oedema scores in the peri-
ovulatory period than mares who had returned to oestrus spontaneously.  
 
Cloprostenol dose and follicular diameter at the time of treatment significantly affected 
the interval from treatment to ovulation. Higher cloprostenol doses from 125 µg 
upwards and large follicles at the time of treatment resulted in shorter intervals to 
ovulation. Mares treated with cloprostenol on day 5 to 7 post-ovulation with an interval 
from treatment to ovulation >7 days, had a higher multiple ovulation rate than mares 
with either a shorter interval from treatment to ovulation or those that ovulated 
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spontaneously. Fertility of mares mated and ovulated soon after cloprostenol treatment 
(4 to 7 days) was reduced by about 20 to 30% compared to mares with longer intervals 
or to untreated mares.  
 
Mares were more likely to develop haemorrhagic anovulatory follicles during oestrus 
after having had cloprostenol treatment than during spontaneous cycles. The incidence 
of haemorrhagic anovulatory follicles was lower during the winter and early spring and 
increased during the summer months. The age of the mare did not significantly affect 
the occurrence of haemorrhagic anovulatory follicles.  
 
In conclusion, the use of cloprostenol in a clinical setting is associated with different 
side effects that are undesirable for equine fertility and management in most cases. The 
majority of these side effects are associated with hormonal changes resulting from 
induced luteolysis at non-physiological stages of the oestrous cycle.  
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INTRODUCTION 
 
Cloprostenol (CLO) is a potent prostaglandin F2α (PGF) analogue that is used commonly 
in equine reproductive practice. The main indications of PGF in the mare are the 
induction of oestrus and the interruption of pregnancy at early stages of gestation by 
lysis of the corpus luteum (CL).   
 
Another indication of PGF is the induction of uterine contractions, which is caused by 
its ecbolic properties. In addition to these recognized phenomena, PGF has other 
reproductive implications in clinical practice. For example, it has an ovulatory effect 
(Arbeiter and Arbeiter, 1985) that becomes more obvious when PGF is administered to 
a mare with a large dioestrous follicle (Loy et al. 1979). This effect is due in part to the 
immediate rise in gonadotrophins following PGF administration (Ginther et al. 2007a). 
PGF has been clinically used under field conditions to stimulate follicular activity in 
anoestrous mares with basal progesterone levels (Jöchle et al. 1987) with variable 
success rates. Furthermore, the use of PGF has been associated with an increase in the 
multiple ovulation (MO) rate in mares (Ginther et al. 2008a). 
 
Since the 1980's, ultrasound equipments have been extensively used in equine 
reproduction to follow and measure ovarian follicles. Particular interest has been paid to 
the diameter of the preovulatory follicle as this is still the single most used criterion to 
estimate the optimal breeding time. Despite this, there is a wide variation in the 
diameters of preovulatory follicles (34 to 70 mm, Ginther 1995). In addition, the 
ultrasonographic characteristics of the development of haemorrhagic anovulatory 
follicles (HAFs) in the mare have been reported (Ginther 1984a, Newcombe 1987). This 
anovulatory condition is considered a distinct cause of infertility in the mare. 
 
The interval from PGF treatment to oestrus and ovulation is highly variable, ranging 
from 2 to 15 days (Lofstedt 1988). Mares have one or two follicular waves during the 
oestrous cycle. In mares that have a single follicular wave, the future ovulatory follicle 
emerges during mid to late dioestrus. Whether a mare has a single or two follicular 
waves is partially influenced by breed (Ginther 1992). 
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Mares and especially Thoroughbreds (TB) are often encountered with large dioestrous 
follicles (>30 mm) during routine stud examinations. If these mares are short-cycled 
with PGF, they may show oestrus shortly after PGF treatment with an overall interval 
from treatment to ovulation (ITO) of usually no longer than 3 to 4 days (Pinto and 
Meyers 2007). It has been suggested that fertility of mares mated and ovulated within 4 
days of PGF treatment is disappointingly low (Pycock 2007). 
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REVIEW OF LITERATURE 
1. Prostaglandin F2α and its analogues 
The prostaglandins are derived from a 20-carbon fatty acid that incorporates one five-
carbon ring. Most body tissues can synthesize prostaglandins from arachidonic acid. 
They have profound and diverse biological effects on the organism as autocrine, 
paracrine or endocrine messengers (Pike 1971). Amongst them, PGF is widely known 
in veterinary medicine for its biological effects on the reproductive system.  
 
1.1. Biological effects and pharmacokinetics  
When PGF reaches the general circulation, it is rapidly metabolized by enzymes into its 
inactive metabolite. About 90% of exogenous PGF is broken down into its inactive form 
within 90 seconds mostly in the lungs and in lesser amount in the liver, which 
demonstrates its very short half life (Pike 1971).  
 
The first therapeutic applications were carried out using naturally occurring PGF 
obtained from corals (Corey et al. 1973). However, such therapeutic treatment was not 
problem free, since PGF acts not only on the CL and myometrium it also acts on other 
organs such as the respiratory and digestive systems. It is upon these organs that PGF 
may have adverse effects, some of which can be fairly serious (Allen and Cooper 1975; 
Miller et al. 1976). Between the end of the 1970's and the beginning of the 1980's it 
became possible to eliminate these drawbacks by synthesizing structural analogues of 
PGF for which the luteolytic activity was much more marked than  the effects on the 
intestinal, bronchial and vessel smooth muscles. 
 
Since the first report of the therapeutic use of PGF to manage the oestrous cycle in the 
mare back in the 1970's (Douglas and Ginther 1972), many reports have investigated the 
use of different synthetic compounds in veterinary medicine. Amongst these synthetic 
compounds, it is worth highlighting alfaprostol (Arbeiter and Arbeiter 1985; Crickman 
et al. 1991), and fenprostalene (Savage and Liptrap 1987) for the induction of ovulation 
in oestrous mares; luprostiol to study the effect of PGF on gonadotrophin release in 
transitional mares (Jöchle et al. 1987); fluprostenol for the induction of abortion in 
mares (Squires et al. 1980); tiaprost for the clinical treatment of endometritis in cattle 
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(Heuwieser et al. 2000); etiproston for luteolysis in dogs (Kirihara et al. 2005); and DL-
Cloprostenol the racemic CLO which is the most widely used PGF analogue in 
veterinary medicine.  
 
All PGF analogues differ from each other in their potencies in mediating luteolysis and 
also in their half lives. In order to investigate the possible ovulatory effect of PGF, 
researchers opted to used analogues with known long half lives extrapolated from other 
species (usually cattle) as in the case of fenprostalene, which has a 24 h half life in cattle 
(Savage and Liptrap 1987). The compound with the shortest half life of less than 1 
minute (Pike 1971) is the native PGF, which also has the least potency. In contrast, the 
most potent PGF analogue available commercially is D-cloprostenol, the dextrorotatory 
isomer of racemic CLO, which is known to be three times more potent than the racemic 
form DL-cloprostenol (Kral 1988). The half life of CLO in rats has been shown to be 54 
minutes (Bourne et al. 1979).  
 
1.2. Uses in equine reproduction 
The two main uses of PGF and its analogues in equine practice are for the induction of 
luteolysis and for myometrial contractions. Luteolysis is indicated for the induction of 
oestrus (Ginther 1992) and termination of early single or twin pregnancies (Ragon 
2007). The stimulation of myometrium activity is indicated for the induction of abortion 
and for the amelioration of impaired uterine clearance (Troedsson et al. 1995; Combs et 
al. 1996; Troedsson 1997). 
 
Currently, the two PGF products most utilized in veterinary practice are CLO and 
dinoprost, a naturally occurring PGF. The recommended dose of dinoprost for induction 
of oestrus in an average sized mare of 500 kg is 11 mg (22µg/kg, Lutalyse® Pfizer). 
Although, the majority of equine veterinarians use a standard dose of 10 mg regardless 
of body weight (Barker et al. 2006). On the other hand, the recommended dose for CLO 
is only 250 µg.  
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Induction of luteolysis 
In the cyclic mare, spontaneous luteolysis was found to occur 12 to 16 days (mean 14.9) 
after ovulation, when fertilization had not occurred (Ginther 1979). This period can be 
shortened by the administration of PGF to the dioestrous mare with subsequent 
induction of oestrus. For many years, the CL had been thought to be unresponsive to 
exogenous administration of PGF during its first 5 days of life (Allen and Rowson 
1973; Bristol 1987; Lofstedt 1988; Ginther 1992). This statement can still be found in 
fairly current veterinary textbooks (Pinto and Meyers 2007). However other recent 
reports have challenged this long standing belief (Troedsson et al. 2001; Nie et al. 
2003a and 2003b; Bergfelt et al. 2006; Newcombe 2007; Tosi et al. 2008). Moreover, 
these and other studies showed that administration of either dinoprost or CLO to mares 
or jennies (Carluccio et al. 2008) with a CL ≤4 days old was able to decrease 
progesterone levels and significantly shorten the interovulatory interval compared with 
non-treated mares.  
 
There appears to be a relationship between the dose of exogenous PGF, age of CL and 
effect on luteal function. However, to date no reports have been published to study this 
relationship critically. The review of several papers (Ginther 1992) shows that when a 
given dose is administered at a certain time after ovulation a complete luteolysis occurs 
(progesterone <1 ng/ml). On the other hand, luteolysis will not, if that same dosage is 
administered earlier in dioestrus. For example, the administration of 500 µg of CLO to 
mares with a CL aged 80 to 88 ± 4 h induced full luteolysis with signs of oestrus within 
5 days of treatment for 58% of treated mares. A further 24 % of mares had a partial 
response (ovulation without signs of oestrus), whereas the remaining 18% did not 
respond. If the same dosage of CLO was administered from 88 to 144 ± 4 h post 
ovulation, the full response rate was 100% (Newcombe 2007). In practice, most 
clinicians administer a single bolus of PGF to dioestrous mares 6 to 10 days post 
ovulation to shorten the oestrous length. The PGF dose used is 10 mg of dinoprost, 
which is far in excess of the minimum luteolytic effective dose. At that stage of the 
cycle, approximately a tenth of the recommended dose (1.25 mg dinoprost) induced full 
luteolysis in all mares treated (Barker et al. 2006). Similarly, 0.2 mg dinoprost / 100 kg 
body weight administered on day 7 of the cycle induced full luteolysis in all treated 
pony mares (Handler et al. 2004). In contrast the same dose did not induce luteolysis if 
given earlier in dioestrus (Irvine et al. 2002). 
 16
Recent studies have shown how different is the method of inducing exogenous 
luteolysis with a single bolus from the actual physiological mechanism of spontaneous 
luteolysis, these have been reviewed by Ginther (2009). These differences are 
manifested by the changes in some reproductive hormones, such as luteinizing hormone 
(LH), follicle stimulating hormone (FSH), cortisol, and progesterone as a result of a 
single bolus of exogenous PGF. During spontaneous luteolysis, the release of PGF from 
the endometrium is pulsatile rather than in a single peak (Ginther et al. 2009a). 
 
Clinical diagnosis of luteolysis 
The most objective way to assess luteal function and the stage of the oestrous cycle is 
by measuring the concentration of progesterone in peripheral circulation by 
radioimmunoassay (Lopate and Threlfall 1991) or by enzyme-linked immunoassay 
(Munro and Stabenfeldt 1984). Although there have been commercially available 
diagnostic kits to qualitatively assess progesterone (Allen and Sanderson 1987) under 
field conditions, successful luteolysis is assessed by the clinical examination of the 
reproductive tract of the mare and by behavioural response to a teaser stallion in the 
field. 
 
Classically, farm staff and veterinarians relied on teasing behaviour to ascertain whether 
a mare was in oestrus. Since then the advent and availability of diagnostic ultrasound 
equipment has made oestrus detection more reliable. Behavioural signs of oestrus in 
mares do not begin until peripheral progesterone concentration falls below 2 ng/ml 
(Nett et al. 1976; Asa et al. 1984). Unfortunately, teasing behaviour alone is not 
completely reliable to assess luteal function since 5 to 10% of pregnant mares 
occasionally may show positive teasing behaviour (Tomasgard and Benjaminsen 1975). 
Furthermore, it is not unusual for mares with basal progesterone and high oestradiol 
concentrations to show a negative or inconclusive response to teasing also known as 
covert or silent oestrus (Ginther 1992). According to Kiefer et al. (1979), about 26% of 
mares had silent oestrus following exogenous PGF administration to induce luteolysis. 
The peripheral concentration of progesterone in mares with silent oestrus declined 
significantly closer to ovulation than in mares with overt oestrus (Nelson et al. 1985). 
Some reports did not find differences between plasma levels of oestrogens in mares 
with silent or normal oestrus (Munro et al. 1979), whereas other studies reported lower 
concentrations in silent oestrous mares (Nelson et al. 1985). 
 17
During oestrus, circulating follicular oestrogens are able to induce the development of 
oedema in individual endometrial folds, which results in alternate and intertwining 
echogenic areas that can be readily visualized by ultrasound examination of the uterine 
horns and body (Ginther 1986). This phenomenon is only possible in the absence of 
peripheral circulating progesterone <1 ng/ml in reproductively normal mares (Pelehach 
et al. 2000). Thus the combination of low progesterone and follicular circulating 
oestrogens greatly facilitates the clinical (ultrasound) diagnosis of oestrus and 
luteolysis.  
 
After exogenous PGF-induced luteolysis, the CL undergoes several changes in 
echogenicity (increase) and diameter (decrease) that can be assessed by 
ultrasonographic examination of the ovaries (Bergfelt et al. 2006). The decrease in the 
cross-sectional diameter of the CL following PGF treatment is usually completed by 5 
days post treatment, after which it is often no longer visible. On the other hand, mares 
with incomplete luteolysis that experience a resurgence in progesterone concentration 
do not show the expected increase in CL diameter (Bergfelt et al. 2006). This lack of 
correlation between the cross-sectional area of the CL and its ability to secrete 
progesterone can be misleading for the diagnosis of oestrus in mares with no obviously 
visible CL though these mares had progesterone concentrations above 1 ng/ml, 
dioestrus-like echotexture and manifested inconclusive teasing behaviour. 
 
 The phenomenon of progesterone resurgence subsequent to incomplete luteolysis has 
been observed after the administration of 10 mg of dinoprost to mares with 3 to 4 days 
old corpora lutea, when 75% of all treated mares underwent a resurgence of 
progesterone (Bergfelt et al. 2006). Despite the incomplete luteolysis, the interovulatory 
interval was significantly reduced in these mares. When a more potent PGF analogue 
(D-cloprostenol: Dalmazin®) was used in mares and jenny mares with corpora lutea of 
similar age, their respective percentages of mares with progesterone resurgence was 
decreased to 45% (Tosi et al. 2008) and to 0 (Carluccio et al. 2008).  
 
Transrectal palpation of the uterus has been routinely used to determine the stage of the 
cycle in mares (Solomon 1971; Greenhoff and Kenney 1975; Baker and Kenney 1980; 
Asbury 1987). During oestrus, the uterus feels relaxed upon palpation, whereas during 
dioestrus an increase in the tone of the tubular genitalia becomes apparent (Hayes and 
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Ginther 1986). The changes in tone during dioestrus are associated with elevated 
progesterone and the disappearance of the endometrial oedema. The evaluation of 
changes in cervical tone and consistency during manual palpation per vaginam and 
transrectal examination has been considered to be useful in estimating the stage of the 
cycle in the mare (Ginther 1992). During dioestrus the cervix resembles a thumb in size 
and consistency. As progesterone declines and oestrogens increases, the cervix loses 
tone, becomes oedematous and opens gradually to a maximum extent as ovulation 
approaches (Greenhoff and Kenney 1975). 
 
Uterine contractility 
Myometrial activity is mediated by several mechanisms: a) hormonal: oxytocin and 
prostaglandins (LeBlanc et al. 1994; Cadario et al. 1995; Combs et al. 1996); b) 
neuronal: autonomic neurotransmitters (Guyton and Hall 1996; DeLille et al. 2000) and 
c) myogenic (Guyton and Hall 1996) interactions. 
 
The involvement of PGF in the mechanism of uterine contractility was manifested by 
the impairment of uterine contractions following the administration of phenylbutazone, 
a blocker of PGF synthesis (Cadario et al. 1995). Classically, PGF was used for the 
treatment of persistent mating-induced endometritis due to its longer half life and its 
action upon the myometrium as compared with that of oxytocin. A standard dose of 10 
mg of dinoprost increased myometrial contractility over 5 h compared with only 1 h 
after the administration of 20 IU of oxytocin (Troedsson et al. 1995).  
 
Despite the prolonged effect of PGF upon the endometrium, it appears that the efficacy 
and safety aspects favour oxytocin over prostaglandins in most cases (Combs et al. 
1996; Troedsson 1997). A study has also shown that when PGF was used in the early 
post-ovulatory period (500 µg CLO on day 2) to aid uterine clearance after mating, the 
luteal function was impaired with the resultant reduction in progesterone levels and 
pregnancy rate (Troedsson et al. 2001). In contrast, when only 250 µg of CLO was 
administered up to day 2 of the cycle, progesterone levels and pregnancy rates on day 
12 were no different to those of untreated controls (Nie et al. 2003a and 2003b) in spite 
of transient reduction in progesterone concentration. 
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The effect of PGF on induction of parturition or abortion in the mare has been studied. 
A single treatment with a PGF analogue (fluprostenol) administered to mares after 
endometrial cup formation was not effective for the induction of abortion (Squires et al. 
1980). However, daily treatments with PGF terminated pregnancy in all mares from 
days 100 to 245 (Ginther 1979) or at day 70 (Squires et al. 1980) of gestation. Most 
mares aborted in the first week, from 3 to 6 days after the first PGF administration. 
However, in some mares, it took 4 weeks of treatment until abortion occurred (<10% of 
mares). The cause of abortion from repeated treatments with PGF must be related to 
uterine contractions and relaxation of cervix because luteal progesterone is not 
necessary for the maintenance of pregnancy after day 75 (Holtan et al. 1979).   
 
1.3. Side effects following treatment with exogenous PGF  
“Side effect” refers to any effect secondary to the main therapeutic effect of PGF in the 
mare (luteolysis). Some side effects can be undesirable due to the activity of PGF on 
smooth muscle, which can result in bronchospasm, sweating and mild diarrhoea. These 
undesirable adverse effects in the mare have been well documented (Allen and Cooper 
1975; Miller et al. 1976) and are not within the scope of this review. In contrast, some 
other side effect derived from the use of PGF may or may not be undesirable for equine 
reproductive practice. Substantial research has been carried out on this subject. Some 
studies have clearly characterized the mechanisms of action of these effects. However, 
others have found only a link between the use of PGF and the occurrence of these 
unexpected events. These side effects include: hastening of follicular development and 
ovulation, increase in MO and reduction in fertility, which will be discussed in the 
following sections.  
 
Follicular diameter 
During a research study on preovulatory follicular diameters, it was noted that mares 
with a CLO-induced oestrus tended to ovulate from smaller preovulatory diameters than 
non-treated mares (Cuervo-Arango 2007). Furthermore, the follicular development and 
growth rate appears to be affected by PGF. The complete cessation in growth 48 h prior 
to ovulation classically observed in follicles of spontaneous waves (Pierson and Ginther 
1985a; Koskinen et al. 1989; Townson and Ginther 1989) does not occur in follicles of 
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PGF-induced waves (Gastal et al., 1998). In the latter study, the daily follicular growth 
rate decreased 2 days before ovulation, but the absolute growth never stopped until 
ovulation.  
 
Induction of ovulation 
The effect of PGF in inducing ovulation was shown in numerous species: in the hamster 
with native PGF (Labhsetwar 1971), in the pig with CLO (Srikandakumar and Downey 
1989) and also in the horse with either alfaprostol (Arbeiter and Arbeiter 1985) or 
fenprostalene (Savage and Liptrap 1987). One report failed to show the ovulatory effect 
of luprostinol in mares (Squires et al. 1988). Squires and co-workers (1988) found that 
the interval to ovulation of mares in the PGF group was not statisticaly different from  
control group, though it did not differ from the human chorionic gonadotrophin (hCG) 
group either. In contrast, the study by Savage and Liptrap (1987) showed an undoubted 
ovulatory effect of PGF in the mare. These authors administered fenprostalene or saline 
to 32 mares (16 in each group) when the mean diameter follicle was around 40 mm for 
both groups. As much as  81% of the fenprostalene treated mares ovulated within 48 h 
whereas only 31% of control mares did so within the same period. Moreover, the 
interval to ovulation and duration of oestrus were significantly reduced.  
 
The mechanism by which PGF is able to hasten ovulation is not fully understood. In 
transitional mares, a PGF analogue (luprostiol) was able to induce an immediate release 
of LH, FSH and gonadotrophin releasing hormone (GnRH) into the peripheral blood 
circulation. The concentrations of these hormones were maintained elevated over 4 h 
(Jöchle et al. 1987). Luprostiol has a half life of 4 h in cattle (Valks 1999) and therefore 
it is expected to have a long lasting effect in target organs also in the horse. The 
administration of native PGF to mid-dioestrous mares also increased FSH and LH for 
12 h (Ginther et al. 2007a). Some clinical studies showed the ability of some PGF 
analogues to induce oestrus in mares with basal or very low progesterone concentrations 
(Howey et al. 1983; Jöchle et al. 1987).  In contrast, alfaprostol did not produce a rise in 
circulating gonadotrophins following administration to oestrous mares (Crickman et al. 
1991) in spite of inducing ovulation (Arbeiter and Arbeiter 1985). It appears that the 
action of PGF in hastening ovulation may occur at the follicle rather than at the pituitary 
level. Studies have shown the active involvement of prostaglandins during the ovulatory 
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process at the follicular level (Murdoch et al. 1986; Sirois and Dore 1997; Murdoch and 
Gottsch 2003). Differences in results between studies might account for the variation in 
half life and potency amongst different types of PGF.  
 
Occurrence of multiple ovulation 
A field study on the relationship between hormone treatments and various reproductive 
outcomes of mares (mainly Standardbreds, Finnhorses and different breeds of riding 
horses) found an association between the use of CLO (125 to 250 µg) and the increased 
occurrence of MO (Katila 2003). However, the age of the CL and the ITO was not 
known, but the interval from PGF administration to insemination was known. They 
found that the interval did not influence the pregnancy rate (PR) but did the MO rate. 
Mares inseminated more than 8 days after CLO treatment had a higher MO rate. 
 
 In a more recent study, the use of PGF was also associated with an increased incidence 
of MO (Dalin et al. 2008). However, the ITO was not taken into account either. A 
subsequent report on hormonal concentration interrelationships between spontaneous 
and PGF-induced cycles anecdotally found an association between PGF-induced 
luteolysis and increased MO rate (Ginther et al. 2008a). This finding was explained in 
part due to the alteration of the process of follicular selection and deviation as a result of 
increased LH concentration in PGF-induced cycles before and during that critical point 
of follicular development. 
 
Fertility following PGF-induced oestrus 
A recent field study found a negative association between the use of PGF to induce 
oestrus and a decrease in PR (Nielsen et al. 2008) in mares inseminated with frozen-
thawed semen. No description of the protocol for using PGF was provided. These 
authors did state that PGF was used mainly in mares who had poor signs of oestrous 
behaviour though. In contrast, Katila (2003) did not find an association between the use 
of CLO and reduced fertility.  
 
In cattle, artificial insemination (AI) of cows after CLO-induced oestrus yielded similar 
pregnancy rate (PR) as that obtained with AI during spontaneous oestrus the conception 
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rates being 59 and 54.5% respectively (Cairoli et al. 2006). Similarly no information on 
the ITO was given. 
 
2. Follicular dynamics  
The mare is a long-day seasonal breeder with a period of ovarian inactivity or deep 
anoestrus during the winter months. There are also two transitional periods, one of 
which precedes the beginning of anoestrus and one that follows the end of the inactivity 
period, respectively termed the autumn and spring transitions. During the spring 
transition, the resurgence in ovarian activity is accompanied by from none to several 
anovulatory follicular waves with large follicles. These often regress until an ovulatory 
follicular wave culminates in the first ovulation of the year. From that point, cyclicity 
will continue normally until the autumn transition and subsequent winter inactivity. 
Follicular dynamics and their interrelationship with the environmental and hormonal 
factors during the anovulatory and ovulatory seasons have been studied and reviewed 
extensively (Ginther 1992). Only reference to follicular dynamics during the ovulatory 
season will be made in the following sections. 
 
2.1. Measurement of follicular diameter 
The study of equine follicular dynamics and diameters has greatly improved over 
conventional methods based on rectal palpation with the introduction of 
ultrasonography (Ginther 1988). 
 
Conventionally, follicles are measured using the electronic callipers of the ultrasound 
scanner. The image of the follicle is frozen at its maximum size, and then the follicular 
diameter is obtained from the average of two linear measurements. The first line is 
drawn at the greatest distance between the opposite walls and the second line at the 
greatest distance at right angles to the first line. This technique described by Ginther 
(1988), has been used ever since, and although there may be some variation in the 
measurement amongst operators measuring follicular diameters is still considered a 
reliable technique (Ginther and Pierson 1989; Gastal et al. 1998).  
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The technique of follicular ablation by transvaginal ultrasound guided aspiration of 
follicles ≥6 mm has been used to standardize the beginning of follicular development 
and the systemic hormone concentrations in relation to follicular development of a 
given wave. Thus it facilitates the measurement and follow-up of follicles and hormones 
during early stages of development (Gastal et al. 2000). Luteolysis is often induced by 
administering exogenous PGF at the time of follicular ablation to remove the influence 
of progesterone on gonadotrophins and follicular development (Gastal et al. 2000; 
Ginther et al. 2008a; Ginther et al. 2008b). 
 
2.2. Follicular waves 
The wave phenomenon 
During the dioestrous phase, mares have either two waves (secondary and primary) or 
just one follicular (primary) wave. Mares with secondary waves grow follicles early in 
dioestrus to varying diameters, which often regress giving way to a new ovulatory 
primary follicular wave. However, on some occasions the dioestrous follicles 
originating from the secondary wave may ovulate (dioestrous ovulations). Mares are 
unique because they are able to ovulate while their progesterone concentrations remain 
high (Hughes et al. 1972; Hughes et al. 1985; Ginther and Pierson 1989; Newcombe 
1997a). In mares with only one follicular wave, the wave usually begins in mid-
dioestrus and one of the follicles is the origin to the ovulation that is associated with 
oestrus (Ginther 1992).  
 
The prevalence of mares with two follicular waves has been reported to be 44% (Sirois 
et al. 1989; Ginther 1990). In these studies, the reported diameter of anovulatory 
follicles from the secondary wave reached 40 mm. The secondary follicular wave 
frequently originated before or at the time of the previous ovulation. The percentage of 
mares with one or two follicular waves is influenced by breed (Ginther 1992). 
Thoroughbred mares have a higher prevalence of cycles with two follicular waves and 
therefore an increased likelihood of having dioestrous ovulations compared with some 
other breeds such as the Quarterhorse or ponies. Mares with one or two follicular waves 
do not appear to differ in the length of the interovulatory intervals. However, if the 
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secondary follicle of a mare with two follicular waves culminates in dioestrous 
ovulation, the interovulatory interval may be lengthened (Sirois et al. 1989).  
 
Follicular diameter in relation to the stage of the cycle 
The interovulatory interval in the mare varies from 16 to 25 days (Ginther and Pierson 
1989), with a mean of 21.7 days. The variation can be explained by breed and seasonal 
factors (Ginther 1979). Pony mares have shorter intervals than horses. The 
interovulatory interval of mares earlier in the season is longer than during the more 
advanced ovulatory season (summer months). This is associated with a lower mean 
daily LH concentration (Turner et al. 1979). This huge variation in interovulatory 
intervals (16 to 25 days) is due mainly to the difference in the length of oestrus rather 
than that of dioestrus itself (Ginther 1979). Follicular dynamics actively influence the 
length of oestrus: within an individual mare the follicular diameter on the first day of 
oestrus, the daily follicular growth rate during oestrus and the diameter of the 
preovulatory follicle are the main factors responsible for the length of oestrus. A shorter 
oestrus will occur, if larger follicles are present at the beginning of oestrus in the 
following situations: if the diameter of the preovulatory follicle is smaller or if the daily 
follicular growth rate during oestrus is faster (Ginther 1979). 
 
The follicular diameter, in relation to the stage of the cycle, will depend on the number 
of follicular waves and on the stage of follicular development during dioestrus. 
Therefore, some mid-dioestrous mares may have follicles less than 20 mm (the 
majority) whereas others may have follicles in excess of 40 mm. In a recent study, the 
distribution of diameters of dioestrous follicles in 147 TB post-partum mares 5 to 7 days 
after the foal heat ovulation throughout the 2009 breeding season (February to August) 
was investigated (Newcombe and Cuervo-Arango 2009). Those authors found that 58% 
of mares had follicles less than 20 mm, 22% follicles of 20 to 29 mm, 16% had follicles 
of 30 to 39 mm, 2% follicles of ≥40 mm and 2% had fresh dioestrous ovulations.  
 
Interval from luteolysis to ovulation 
During spontaneous cycles, luteolysis occurs in the majority of mares, if conception has 
not taken place. However, in some breeds (TB and Quarterhorses), for up to 15 to 25% 
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of oestrous cycles, the primary CL persists and thus prolongs the luteal phase from 20 to 
80 days (Stabenfeldt et al. 1974; Newcombe 1997a). Reasons for the prolonged luteal 
activity appear to be due to either the ovulation of a dioestrous follicle shortly before 
luteolysis of the primary CL or a failure of the endometrium to release PGF (Neely et al. 
1979). 
 
Spontaneous luteolysis occurs at a mean of 14.9 days post ovulation (Ginther 1979). At 
luteolysis progesterone concentration begins to decline gradually from 11 to 14 days 
from 12 to 9 ng/ml and sharply from 14 to 17 days from 9 to 2 ng/ml (Townson et al. 
1989). However, this pattern of progesterone decline is subject to individual variation. 
The mean interval from spontaneous luteolysis to ovulation is 6.8 days with longer 
intervals early and late in the ovulatory season. In addition, the length of oestrus tends 
to be repeatable within individual mares (Ginther 1979).  
 
During exogenously induced luteolysis, progesterone concentration declines much more 
sharply and rapidly than by spontaneous luteolysis: a single administration of 10 mg of 
dinoprost to mid-dioestrous mares 10 to 11 days post ovulation decreased progesterone 
concentrations from 14.5 to 2.5 ng/dl in only 24 h. Progesterone continued to decrease 
to basal levels from 2.5 to < 1 ng/dl during the following 24 h, that is, 48 h post-
treatment (Bergfelt et al. 2006).  
 
The interval from PGF-induced luteolysis to ovulation is highly variable in the mare and 
occurs at a median of 9.5 days (range: 1 to 15 days) (Loy et al. 1979; Lofstedt 1986) 
regardless of the day of treatment (Bergfelt et al. 2006). Although time of season may 
account for some variation, in a comparable fashion to the different length of oestrus 
observed in spontaneous luteolysis, this great variation in the length of interval to 
ovulation is mainly dependant on the follicular diameter of the largest follicle at the 
time of PGF treatment (Asbury 1988). In a recent study (Bergfelt et al. 2006), 
administration of PGF to Quarter Horse and Appaloosa mares yielded different intervals 
from treatment to ovulation. The interval was negatively correlated (r = - 0.57 and r = - 
0.74 in mares treated on days 3 and 10 post-ovulation, respectively) with the largest 
follicular diameter occurring at the time of treatment. Although the correlation was 
significant, the Pearson’s coefficients indicated only a good to fair level of association. 
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2.3. Diameter of the preovulatory follicle 
Much attention has been paid over the years to the diameter of the preovulatory follicles 
and to the factors that influence it. This research interest is due to the fact that 
preovulatory follicular diameter still remains the principal criterion in the estimation of 
the optimal time for breeding. 
 
There is a major influence of breed on the variation of follicular diameter in the mare 
(34 to 70 mm; Ginther 1995). Large draught breeds (Clydesdale, Shire, Irish Draught 
and Warmbloods) have larger diameters than lighter breeds (pony breeds, TB and 
Standardbred). The month also has a significant effect on the preovulatory follicular 
diameter because of variations in the average daily concentration of LH (Ginther and 
Pierson 1989) and within the same breed of mares (Quarter Horses). Moreover, Ginther 
and Pearson (1989) reported a mean difference of 8 mm in the preovulatory diameter of 
follicles between ovulations in May (48 mm) and July (40 mm).  
 
The number of follicles that ovulate during the same oestrus also accounts for some of 
this variation in follicular diameter. Double preovulatory follicles have smaller 
diameters than single follicles (Ginther and Pierson 1989). Within double ovulation 
cycles, follicles from unilateral ovulations had smaller diameters than those from 
bilateral ovulations. In contrast, an earlier study did not find any difference in follicular 
diameters between single and multiple ovulatory follicles (Squires et al. 1987a). 
 
The preovulatory follicular diameter during spontaneous cycles remains constant during 
the last 2 days before ovulation or even becomes slightly smaller within 24 h of 
ovulation (Koskinen et al. 1989). Administration of hCG to mares for induction of 
ovulation initiates a cessation in follicular growth from the time of the treatment (Gastal 
et al. 2006a). Therefore it reduces the ultimate preovulatory follicular diameter, if the 
follicle had not already completed its growth. 
 
Unfortunately, even within the same breed or season, there is a strong individual mare 
factor that accounts for the variation in the preovulatory follicular diameter, which may 
preclude the reliable estimation of breeding time based just on follicular diameter 
(Ginther 1992). Studies on repeatability of preovulatory follicular diameters amongst 
individual mares have not been carried out. 
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2.4. Multiple ovulation  
The mare is considered a monovular and monotocus species, but it is not uncommon to 
find MO which may or may not culminate in multiple pregnancies. Classically, a MO is 
defined as more than one ovulation originating from two different follicles 0 to 2 days 
apart within the same oestrus (Ginther 1992). A second ovulation after this period often 
occurs during the subsequent dioestrus and should be termed more correctly as a 
dioestrous ovulation. The MO rate in the mare has been reviewed and varies from 2 to 
43% (Ginther 1992). 
 
Hormonal mechanisms 
In monovular species, only one of many available follicles develops into the dominant 
or ovulatory follicle. This phenomenon is known as follicle selection. Follicles develop 
in waves. All selected follicles grow at a similar rate until the point when the largest 
(dominant) follicle keeps growing at the same rate at which time the remaining follicles 
experience a reduction in growth rate. This change in follicular growth is termed 
follicular deviation (Ginther 2000). 
 
In the mare, follicle deviation begins when the largest follicle reaches a diameter of 22.5 
mm (Ginther et al. 2003). At that point, FSH concentration has already decreased 
substantially (the decline starts three days before deviation) as a result of increasing 
inhibin secretion (Donadeu and Ginther 2001) while LH concentration has begun to 
increase (Bergfelt et al. 2001). The dominant follicle being in a more advanced 
developmental stage is able to cope with the reduced FSH due to the positive effect of 
LH on follicular growth. Moreover, the dominant follicle is able to respond to 
increasing LH concentrations to a greater extent due to the higher expression of LH 
receptors on its wall as compared with the less developed subordinate follicles (Ginther 
et al. 2003).  
 
The LH and FSH secretion patterns before and during deviation are critical to the fate of 
the selected follicles (Ginther et al. 2009b). In contrast, measurement of gonadotrophins 
during the last few days before ovulation in single and double ovulating mares did not 
reveal any obvious differences in their concentrations (Ginther et al. 2008c). On most 
occasions during spontaneous cycles, only one (the largest follicle) continues to grow 
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and ovulate. A review of several studies on the administration of exogenous 
gonadotrophins in enhancing MO rate has shown the importance of the timing of the 
treatments in relation to the stage of follicular development on the ovulatory response 
rate (Squires and McCue 2007). 
 
Factors affecting multiple ovulation rate 
The highest incidence of MO is found in TB mares whereas native pony mares have the 
lowest incidence. The reported incidences for different breeds are as follows: TB 25 to 
15%, draught horses 24%, Standardbreds 15 to 13%, Quarter Horses and Appaloosa 8 
to 10% and pony mares 2 to 3% (Ginther 1986). This marked difference between breeds 
is believed to originate from a high degree of heritability of this factor (Squires et al. 
1987b). 
 
Foaling mares have been reported to have a lower MO rate than maiden or barren mares 
(Ginther et al. 1982). Ginther and co-workers (1982) reported a MO rate of 16% in post-
partum TB mares compared with 30 and 27% in barren and maiden mares, respectively. 
Four combined slaughterhouse studies (Osborne 1966; Wesson and Ginther 1981; 
Henry et al. 1982; Saltiel et al. 1982) yielded interesting results showing a gradual 
increasing pattern in MO rate from the winter months (7%) to mid-summer (14%) to 
decrease again during the autumn (10%). It can be hypothesized that the seasonal 
increase in MO as the year advances follows the pattern of daily mean LH 
concentrations with peak MO incidence during the months of highest LH concentrations 
namely the summer months. There can also be confounding factors such as the higher 
proportion of post-partum mares early in the season who have an intrinsically lower MO 
incidences and a higher proportion of aborted mares with supplementary corpora lutea 
in the autumn.  
 
Finally, the age of the mares has a clear effect on the MO incidence. In a study 
involving TB mares, the MO rate increased with age (Davies-Morel et al. 2005). The 
MO rate increased from 20.7% in mares aged between 2 to 4 gradually to 35.6% in 
mares aged 17-19 years to decrease gradually again to 27.8% in mares aged 23 or older. 
The positive correlation between age and increase in MO has also been reported in other 
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studies (Henry et al. 1982; Sanderson and Allen 1987; Davies-Morel and O’Sullivan 
2001).  
 
Fertility of multiple ovulations 
The number of embryos per ovulation (embryo rate) is lower for MO than for single 
ovulations (Ginther and Bergfelt 1988; Newcombe 2004; Davies-Morel et al. 2005; 
Balbuena et al. 2008). Ginther and Bergfelt (1988) reported an embryo rate of 85% 
(85/100) for single ovulations compared with 69% (69/100) for double ovulations. 
Embryo rate as detected by ultrasound was higher for bilateral ovulations (77%) than 
for unilateral ovulations (60%). Fifty mares who had twin ovulations conceived 28 sets 
of twin embryos (56%), 13 single embryos (26%) and 9 did not conceive (18%) at all. 
Mares with bilateral double ovulations (26) had 16 sets of twins (61.5%) and 8 single 
embryos (30.7%) whereas mares with unilateral twin ovulations (24) produced 12 sets 
of twins (50%) and 8 single embryos (33%).  The reason for the reduced fertility with 
higher MO is not known, but several hypotheses on early inter-embryonic competition 
in the oviducts and uterus have been proposed (Ginther 1998; Newcombe 2004). 
 
3. The ovulatory period 
3.1. Ultrasonographic signs of impending ovulation 
Preovulatory follicular diameter alone does not seem a reliable criterion to predict the 
time of ovulation due to the great variability in the diameter during the last day prior to 
ovulation. From March to May 21% of native pony mares ovulated follicles between 31  
and 35 mm, 74% between 35 and 40 mm, and only 5% ovulated a follicle >40 mm 
(Gastal et al. 1998). Results of the same study showed an increase in the echogenicity of 
the granulosa and prominence of an anechoic layer, which were maximal between 2 to 1 
days before ovulation. In addition, in the majority of the preovulatory follicles (85%) 
the wall thickness increased and the shape changed from spherical to non-spherical 
(pear-shaped or conical) at some point during the last 3 days before ovulation (Pierson 
and Ginther 1985a). None of these signs alone could be used reliably to predict the time 
of ovulation because of the lack of consistency of the signs amongst mares.  
 
 30
If daily follicle examinations are possible, the detection of cessation of follicular growth 
can be helpful to detect an impending ovulation. In spontaneous cycles the follicle stops 
growing 48 h before ovulation during the rising LH surge (Pierson and Ginther 1985a; 
Koskinen et al. 1989; Townson and Ginther 1989; Gastal et al. 2006a). 
 
3.2. Hormonal mechanisms of the ovulatory process 
In spontaneous and also in hCG-induced ovulations, LH begins to increase (surge) at 48 
h before ovulation, then peaks 36 h post-ovulation and returns to basal levels 96 h post-
ovulation (Gastal et al. 2006a; Ginther et al. 2009c). The LH surge, amongst other 
effects, initiates a cascade of proteolytic activity (Robker et al. 2000). This is driven by 
enzymes such as matrix metalloproteinases and plasminogen activators / plasmin, which 
are required in mediating the tissue remodelling that accompanies the ovulatory process 
(Smith et al. 2002; Riley et al. 2004) needed for the evacuation of follicular fluid and 
oocyte.  The same preovulatory LH surge induces prostaglandin synthesis by granulosa 
cells (Sirois and Dore 1997), which has been proven in numerous species to be essential 
for ovulation to occur. The administration of prostaglandin synthesis inhibitors, given 
either intra-follicularly or systemically, caused luteinization of follicles without 
previous rupture and oocyte release in several species (Armstrong and Grinwich 1972; 
Grinwich et al. 1972; Killick and Elsein 1987; Salhab et al. 2003).  
 
3.3. Ultrasonographic and clinical detection of ovulation 
There are different ultrasonographic signs indicative of impending ovulation in the 
follicle: increased prominence of the anechoic band surrounding the granulosa layer, 
increased thickness and echogenicity of the granulosa layer, loss of spherical shape of 
the follicle, serration of the basal part of the granulosa layer, presence of echoic specks 
within the follicular antrum and decrease in colour-Doppler signals in the apical part of 
the follicle. All this signs have been reviewed (Gastal et al., 1998; Ginther et al., 2007c). 
In equine practice, the accurate detection and timing of ovulation is important for the 
following reasons: a) to ensure the rupture and collapse of the follicle and so assume 
proper release of the oocyte in order to differentiate this from pathological anovulatory 
conditions; b) to ensure that ovulation has occurred within the time window considered 
adequate after pre-ovulation mating; c) to decide the optimum time for breeding with 
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short-lived semen (frozen semen) for post-ovulation AI; d) to determine accurately the 
embryo age necessary for embryo flushing and recovery; and e) to determine accurately 
the number of ovulations in relation to the number of pre-existent follicles in order to 
manage any possible twinning properly.  
 
The frequency of examination of the ovaries is paramount in order to detect ovulation 
accurately. However, if the clinician is not able to recognize the clinical signs of 
ovulation, then the frequency of examinations is of no use.  
 
Palpation of the genital tract 
During the first 12 to 15 h after follicular collapse, the ovulation area within the ovary 
can be digitally palpated as a large soft depression, which in most cases will cause mild 
but evident discomfort to the mare (Newcombe 1987; Ginther 1992). One study 
reported 91% accuracy for the detection of ovulation by transrectal palpation (Michel et 
al. 1986) when the side and diameter of the pre-existent follicle(s) was known. 
 
The manual examination of the cervix per rectum or vagina can also be a useful aid in 
the detection of ovulation. If the ovaries do not have any large follicles and the uterine 
oedema is not obvious, but the mare shows positive teasing behaviour, the manual 
palpation of a relaxed, open and moisture cervix will indicate the presence of a fresh 
ovulation (Greenhoff and Kenney 1975).  
 
Ultrasonographic appearance of ovulation and early corpus luteum 
Follicular fluid evacuation during ovulation in the mare follows two distinct patterns: 
gradual and abrupt evacuation of fluid (Townson and Ginther 1987) when either 90 or 
50% of the antral area disappears within 60 seconds in mares with a respective abrupt or 
gradual evacuation pattern. The gradual follicular evacuation takes 6 to 7 min to 
completion. In the majority of ovulations, some residual follicular fluid persists within 
the ovulation area after the end of the follicular collapse, which may be 
ultrasonographically detectable for up to 20 h (Townson and Ginther 1988; Newcombe 
1996).  
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During the first 12 to 15 h post-ovulation, the ovulatory site appears in ultrasounds as a 
hypoechoic area with or without residual fluid before it increases gradually in 
echogenicity and the borders of the new developing early CL or corpus 
haemorrhagicum (CH) become defined (Newcombe 1996). The high echogenicity of the 
CH is apparent during 3 to 4 days after ovulation (Pierson and Ginther 1985b; 
Newcombe 1996; Newcombe 1997b). 
 
The early CH of some mares, which was reported to be the 68% of 22 luteal glands 
(Townson and Ginther 1988) fills with varying amounts of fluid forming a central 
lacuna. The proportion of ovulations that develop into a CH with a central lacuna has 
been reported to be up to 50% (Newcombe 1997b). The accumulation of fluid begins 20 
to 30 h post ovulation, the central lacuna increases in size as more fluid accumulates 
reaching its maximum diameter at 72 h post-ovulation (Townson and Ginther 1988; 
Newcombe 1996 and 1997b). The origin of the fluid is thought to be vascular since 
during later stages of development of the CH, when visualized by ultrasound the fluid 
clots and the material inside the central area acquires a static appearance as a network of 
hyperechoic lines, which presumably are originated from the fibrinization of blood 
(Ginther and Pierson 1984a). 
 
The biological and clinical relevance of the occurrence and development of this central 
lacuna has not been elucidated. The length of the luteal phase or of the interovulatory 
interval of mares with a solid CL did not differ from those with a central cavity (Pierson 
and Ginther 1985b) nor did the progesterone concentrations differ (Townson et al. 
1989). Individual mares did not necessarily repeat the pattern of CH formation in 
subsequent cycles or in MOs during the same oestrus. The occurrence of the central 
lacuna formation within the CH appears to be incidental without any apparent function 
or negative effects.   
 
3.4. Ovulatory failure 
The mare is a seasonal long-day breeder. The incidence of ovulation is minimal or 
absent during the winter and maximal during the summer. There are two transition 
periods between summer and winter, which are characterized by the regression of large 
anovulatory follicles before the first ovulation of the year (spring transition) and 
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following the last ovulation of the year (autumn transition). In contrast, anovulation of 
large preovulatory size follicles, after the ovulatory season has begun, is unusual and 
should be considered pathological.  
 
The ovulatory failure of follicles during the ovulatory season may adopt different 
patterns. On most occasions, the preovulatory follicle fills with blood with subsequent 
wall luteinization without preceding follicular collapse (Ginther et al. 2007b; McCue 
and Squires 2002). Less frequently, in 13% of anovulatory follicles (McCue and Squires 
2002), the blood-filled follicle fails to luteinize and may remain constant in size for 
several days before regressing. On very rare occasions, a preovulatory sized follicle will 
luteinize without haemorrhage (Newcombe 2010). Fortunately, this last condition is 
very unusual. This clinical condition is very difficult for the practitioner to diagnose, 
because the follicle only undergoes subtle changes in the form of increasing thickness of 
the wall as the mare goes out of season.  
 
For the purpose of this section, any form of anovulatory condition will be termed as 
haemorrhagic anovulatory follicle (HAF), which refers to unruptured haemorrhagic 
luteinized follicle and which is the most frequent form of anovulation in the cyclic 
mare. 
 
History of anovulatory conditions in domestic species and humans 
Failure to ovulate the dominant follicle and the subsequent persistence of the 
anovulatory unruptured structure has been reported to occur in several domestic animal 
species and in humans. This phenomenon has been demonstrated to occur naturally in 
cows (Garverick 1997; Peter 2004), mares (Ginther and Pierson 1984b; Newcombe 
1987; Ginther 1992; McKinnon 1997; Ginther et al. 2007b) and women (Marik and 
Hulka 1978; Coulam et al. 1982; Katz 1988; Toda 1990; Check 2007). This 
phenomenon might occur naturally in all domestic species. However, only in these 
species such as the bovine and the equine, in which follicular dynamics are easily and 
routinely followed ultrasonographically, are there sufficient numbers of observations to 
characterize this syndrome.  
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Haemorrhagic anovulatory follicles in mares 
Haemorrhagic anovulatory follicles have been referred to in different ways. The  first 
reference to what seemed to be the same sort of follicle was made in the 1940's 
(Burkhardt 1948) in which it was described as the occurrence of large persistent 
follicles during the months of October to November. Later in the century they were 
given the name of “autumn follicles” (Knudsen and Weiert 1961) as they were reported 
to occur more frequently at the end of the ovulatory season. Ginther (1979) was the first 
to describe the macroscopic features of these anovulatory follicles, which were defined 
as blood-filled structures with the presence of luteal tissue in the surrounding wall and 
so termed “haemorrhagic follicles”. The first report that describes the ultrasonic 
characteristics of HAFs was made by Ginther and Pierson (1984b).  With the 
widespread introduction and use of ultrasound scanners in the 1980's, several studies 
reported the occurrence of this anovulatory condition in different populations and 
breeds of mares (Newcombe 1987; Townson and Ginther 1988; Ginther and Pierson 
1989; Carnevale et al. 1989; Ginther 1992). Colour-Doppler imaging techniques can be 
used to study the vascularisation of the wall of HAFs (Ginther et al. 2006a and 2007b). 
 
Ultrasonographic appearance of equine  haemorrhagic anovulatory follicles 
The preovulatory fluid-filled follicle of anechoic echotexture fills with echoic specks, 
which float freely in the follicular fluid and swirl if balloted. In the absence of follicular 
collapse, the granulosa layer becomes increasingly echoic and thicker. The number and 
echogenicity of the intrafollicular specks increase but maintain their mobile/swirling 
appearance. The follicle diameter increases due to further entry of blood into the 
follicular antrum and eventually the contents acquire a static organized appearance with 
or without formation of fibrin strands. In the case of formation of fibrin strands, these 
may quiver upon ballottement for a varying  period of time before they become firm. 
Luteinization of the follicle is assumed when the follicular wall becomes highly echoic 
and thickened, the uterus acquires a dioestrus-like echotexture and upon manual vaginal 
examination the cervix feels contracted and increasingly tonic as following normal 
ovulation (Ginther and Pierson 1984b; Newcombe 1987; Ginther 1992). A similar 
condition in women has been termed luteinized unruptured follicle syndrome and the 
ultrasound features of its development (Coulam et al. 1982) resemble those described 
for HAFs in mares. 
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The oestrus of mares preceding HAF formation has a normal length and normal pattern 
of endometrial oedema similar to that seen in normal ovulatory cycles (Ginther et al. 
2007b; McCue and Squires 2002). Following the luteinization of HAFs, the mare enters 
a luteal phase, which is normal in length as evidenced by a dioestrus-like echotexture of 
the uterus and a negative response to teasing (Ginther and Pierson 1989; Ginther et al. 
2006a and 2007b). 
 
Allen (1979) showed that pregnant pony mares under the constant effect of eCG (equine 
chorionic gonadotrophin) presented ovaries with haemorrhagic follicles which 
subsequently luteinized in a similar fashion to that observed in cyclic mares with HAFs. 
Although the endometrial cups are supposed to be sloughed off between 70 and 100 and 
disappeared by day 130 of gestation (Clegg et al., 1954), the persistence of the cups for 
longer especially after abortions has been reported (Steiner et al. 2006). In these cases 
the mare will not cycle regularly and their ovaries may present some forms of 
haemorrhagic follicles. 
 
Clinical relevance of haemorrhagic anovulatory follicles in the mare 
The main relevance of this condition lies in the failure of the dominant follicle to 
collapse. It is assumed that the oocyte cannot be released without follicular collapse and 
fluid evacuation. Histological studies on methods of contraception using rabbits have 
found degenerated oocytes retained in experimentally induced unruptured follicles 
(Salhab et al. 2003). Therefore it is expected that in mares with HAFs and without 
normal concurrent ovulation, fertilization is not possible. The mating of 71 mares with 
solitary HAFs yielded no pregnancy (McCue and Squires 2002). However, due to the 
low incidence of HAFs respectively reported as 4.7 and 8.2% by Ginther and Pierson 
(1989) and McCue and Squires (2002), the overall impact on fertility was low. 
Nevertheless, it can be frustrating for the practitioner dealing with pre-ovulation 
breeding by either natural mating or AI with chilled or frozen semen, when to take the 
decision to breed a mare. As such decision usually is based on a normal dominant 
follicle, which then fills with blood and luteinizes without rupturing leaving that cycle 
with no chance of conception. It appears impossible that when using real-time B-mode 
ultrasonography to distinguish between a preovulatory follicle that will collapse 
normally and ovulate and another one that will haemorrhage.  
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It has been shown that mares with either a HAF cycle or an ovulatory cycle share 
similar endometrial oedema patterns and reproductive hormonal profiles during the 3 
days prior to ovulation or haemorrhage (Ginther et al. 2007b). The relevance of this 
condition on fertility can increase dramatically in individuals that tend to have 
recurrence of HAFs in subsequent cycles (Ginther et al. 2006a) so called “repeater 
mares”.  
 
The therapeutic options for treating HAFs are limited (McCue and Squires 2002). Only 
in valuable “repeater mares” with known high individual HAF recurrence rate, the 
aspiration of oocytes from preovulatory follicles before expected haemorrhage by an 
ovum pick-up technique was successfully conducted (Carnevale 2004). It therefore 
seems important to design and carry out studies to find possible risk factors for the 
development of HAFs so that these can be avoided in mares with a known 
predisposition to this anovulatory condition. 
 
Hypotheses on the pathogenesis of equine haemorrhagic anovulatory follicles  
The pathogenesis of HAFs is unknown. Some studies have associated the occurrence of 
this anovulatory condition with the season and reported a higher incidence in the 
autumn (Burkhardt 1948; Knudsen and Weiert 1961). An increase from 5 to 20% in the 
incidence of HAFs was found between the early and late ovulatory season, respectively 
(Ginther et al. 2007b). In contrast, a long term study of 8 mares over 2 years, in which 
12 HAFs from over 213 interovulatory intervals were followed did not show an effect 
of month (Ginther and Pierson 1989). There appears to be an effect of increased age on 
HAF incidence (McCue and Squires 2002; Ginther et al. 2007b). Mares aged 6 to 10 
had a 4.4% incidence of HAFs compared with 13.1% for mares 16 to 20 years old 
(McCue and Squires 2002). 
Some authors have claimed an insufficient production of follicular steroids (Pierson 
1993) and inadequate stimulation of gonadotrophins (McKinnon 1997) as the 
underlying causes of ovulatory failure. However, later studies have found no difference 
in circulating gonadotrophin concentrations during the last three days before HAF 
formation (Ginther et al. 2007b). Oestradiol concentrations in mares on day 3 before 
HAF formation were slightly higher than in mares with ovulatory cycles. Furthermore, 
endometrial oedema of mares with HAF cycles followed a similar pattern to that of non-
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HAF mares (McCue and Squires 2002), which demonstrates the steroidogenic capacity 
of follicles destined to haemorrhage. Another proposed hypothesis is the repeated used 
of ovulation inducing drugs (Lefranc and Allen 2003). In contrast, McCue and Squires 
(2002) did not find any association between the use of hCG and HAF occurrence as 
they reported 58% of HAF cycles had been treated with hCG whereas the remaining 
42% had not.  
 
To date there is not enough information gathered on the nature of equine HAFs to 
speculate on the pathogenic mechanisms of this anovulatory condition. The incidence of 
a similar condition described in humans known as luteinized unruptured follicle 
syndrome is increased in women who have undergone superovulation programmes with 
clomiphene, a steroid receptor inhibitor that increases circulating concentrations of FSH 
and LH (Zhu 1989). On the basis of that link and studies that showed the effect of 
LH/hCG on the metabolism of intrafollicular PGF and PGE2 (Channing 1973), 
researchers using humans as the subjects have hypothesized that, if LH/hCG stimulation 
of a follicle occurs too early, premature luteinization can result with a consequent 
increased PGE2 synthesis, decrease in PGF synthesis and inhibition of follicular rupture 
(Coulam et al. 1982).  
 
The relevance of prostanoids on the ovulatory process and in the pathogenesis of 
anovulation has been confirmed by several studies, which experimentally induced 
luteinized unruptured follicles by administering either systemically or intrafollicularly 
inhibitors of prostaglandin synthesis in rabbits (Salhab et al. 2003; Grinwich et al. 
1972), rats (Armstrong and Grinwich 1972) and humans (Killick and Elsein 1987). 
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AIMS OF THE STUDY 
 
Clinical data of ultrasound and other reproductive records of ovarian and uterine activity 
from mares with spontaneous or CLO-induced oestrous cycles were analyzed to: 
 
1. assess the degree of repeatability in the diameter of the preovulatory follicle, 
elucidate the pattern of uterine oedema between consecutive spontaneous 
oestrous cycles, and to determine whether this is influenced by hormonal 
treatments, 
 
2. evaluate the interrelationship between CLO dose and follicular diameter and also 
with  the interval from the CLO treatment to ovulation, 
 
 
3. determine the effect of the interval from CLO treatment to ovulation on PR and 
MO rate, and 
 
4. investigate the association of different factors treatment with CLO and hCG, 
season and age of mare with the development of HAFs. 
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MATERIALS AND METHODS 
 
Data were collected from mares resident at two different locations: a veterinary clinic 
specialized in equine reproduction, Warren House Equine Fertility Clinic, Brownhills, 
UK (studies I, III, IV and V), and a TB stud farm in Shropshire, UK (studies II, III). All 
data were obtained from clinical material, therefore no use of experimental animals 
were required.  
 
1. Animals 
The records of 1812 oestrous cycles obtained from 596 mares were analyzed in 4 
studies (I, III, IV, and V). In study II, 1234 oestrous cycles from an undetermined 
number of TB mares were analyzed. The weight of mares was not recorded. All mares 
on the stud farm were TB, whereas the mares in the clinic were mainly Irish Draught, 
Standardbred and Warmblood breeds. Their ages ranged from 2 to 26 years. Most of the 
mares in studies I, IV and V were barren, whereas the majority of the remaining mares 
(II, III) were foaling mares.  Data on matings and PR were only used in study III. The 
mares were naturally mated by 5 TB stallions of known fertility. The animals were 
pastured on paddocks most of the time and fed grass, haylage and cubed cereal 
concentrates. The mares at the clinic were also stabled during mid to late oestrus when 
they approached ovulation. Most of the data were obtained during the breeding season 
(March to September). However a small number of mares, which remained in the clinic 
throughout the year, were the source of data covering the winter months in studies IV 
and V.  
 
2. Ultrasonography 
Ultrasound imaging of the genital tract (uterus and ovaries) was performed transrectally 
following manual palpation of the whole tract. Although they changed over the years, 
the ultrasound scanners were always equipped with a linear array transducer set between 
5 to 7.5 MHz. The frequency of ultrasound examinations varied among studies. Mares 
at the clinic were examined more frequently: once daily during oestrus and up to three 
times a day when the ovulation time was expected. The decision on when to start to 
examine a mare three times a day was made according to the day of the cycle, an 
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observed decreasing endometrial oedema, the diameter of the follicle and its consistency 
on rectal palpation. Routine ultrasound work on the stud farm was done every other day. 
Ultrasound examinations were conducted by the same operator (studies II and III by J.R 
Newcombe; studies I and V by J. Cuervo-Arango), whereas in study IV several 
veterinarians took part in the data collection. However, the data were always recorded in 
the same way. The following end points were recorded by ultrasonography: 
 
2.1. Follicular diameter 
Follicular diameter was obtained from the mean of two linear measurements of the 
antrum which were taken at right angles to each other when the diameter of the follicle 
obtained by the electronic callipers was maximum. In order to determine the accurate 
diameter of preovulatory follicles (I) and to minimize errors in the measurement, the 
preovulatory diameter was obtained from the mean of the diameters of the last three 
examinations before ovulation. At the last examination before detection of ovulation, a 
follicle with an irregular shape and/or collapsing was often found which made it 
difficult to measure accurately. On these occasions, the data were excluded from the 
aggregated readings and only the previous two examinations were used to obtain the 
means. The number of follicles, diameter and their location at each ovary were recorded 
at each examination. 
 
2.2. Ovulation and early corpus luteum 
Ovulations were detected using transrectal palpation and ultrasonography. The absence 
of the previously recorded follicle and the presence of a hypoechoic area within the 
same ovary upon palpation and using ultrasound indicated ovulation also as described 
by Newcombe (1996). Ovulation was later confirmed on ultrasound by the presence of 
an echoic CH. The date of ovulation was recorded as the day on which the absence of 
the follicle was first detected. A mare that had two or more ovulations during the same 
oestrus was considered to have MO. The interval from the first to the last ovulation had 
to be ≤2 days. Although the majority of MOs recorded in study III were double 
ovulations (93%), some triple (6.2%) and quadruple ovulations (0.9%) occurred. 
Occasionally mares on the stud farm were found to have ovulated between examinations 
(usually two days interval). In such cases the ovulation site or CH were studied 
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carefully and an estimation of the ovulation time was made according to shape and the 
echogenicity of the ovulation site as described by Newcombe (1996). 
 
2.3. Haemorrhagic anovulatory follicles 
Haemorrhagic anovulatory follicles were evaluated and diagnosed as described by 
Ginther (1992). In brief, the previously fluid-filled follicle of anechoic echotexture fills 
with echoic specks which float freely in the follicular fluid and swirl when balloted. The 
granulosa layer becomes increasingly echoic and thicker when no follicular collapse 
takes pace. The number and echogenicity of the intrafollicular specks increase but still 
have a mobile/swirling appearance. The follicle diameter increases and eventually the 
contents acquire a static organized appearance. Luteinization of the follicle was 
assumed when the follicular wall became highly echoic and ‘thickened’. At this stage 
the uterus acquired a dioestrus-like echotexture, and on manual examination per 
vaginam, the cervix felt contracted and increased in tone similar to that following 
normal ovulation.The day when the follicle was first seen with haemorrhage (echoic 
specks), was considered as day 1 (day of expected ovulation). 
 
2.4. Endometrial oedema 
Uterine oedema was subjectively assessed under transrectal ultrasonography of the 
uterine horns and body. Uterine oedema was scored on a scale from 0 to 4 in increments 
of 0.5 depending on the size and prominence of the endometrial folds. The hyper- and 
hypoechoic radiations characteristic of endometrial oedema were graded subjectively 
as: 
 
- 0: a homogenous endometrium coincident with that of a “diestrous-like 
echotexture”, 
 
- 0.5: slight oedema, 
 
- 1.0: definite but mild oedema, 
 
- 1.5: mild to moderate oedema, 
 
- 2.0: moderate oedema, often the maximum level seen during normal oestrus, 
 
- 2.5: moderate to heavy, 
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- 3.0: heavy oedema, only occasionally seen during normal cyclicity, and 
 
- 4.0: gross oedema, in excess of that seen during normal cyclicity. 
 
2.5. Pregnancy diagnosis 
Pregnancy diagnosis was performed 12 to 13 days after ovulation. The ultrasound 
examination was carefully performed by imaging the whole uterus starting from the tip 
of a horn to the tip of the other horn then moving down to the uterine body and cervix. 
A mare was diagnosed as pregnant when a round embryonic vesicle was identified 
within the uterus. The number, location and diameter of embryonic vesicles were 
recorded for each mare.  
 
3. Hormonal and post-mating treatments 
The following drugs were used in some or in all studies: 
 
3.1. Cloprostenol 
Cloprostenol (Estrumate®, Schering-Plough Animal Health Ltd, Welwyn Garden City, 
UK; 250 µg CLO/ml) was always used in dioestrus to cause luteolysis and administered 
subcutaneously. The dose varied in all studies, especially in study II. The reason for 
using different doses of CLO was the age of the CL: larger doses were administered to 
mares in early dioestrus whereas lower doses of CLO were administered later in the 
luteal phase or to mares with a prolonged dioestrous phase. In general, 250 µg CLO 
were used in mares 5 to 7 days post-ovulation, 500 µg to <5 days and 125 µg >7 days.  
 
In study II, CLO doses ranged from 8.75 to 625 µg. irrespective of body weight. Doses 
of <75 µg were calculated by the administration of a 20x dilution in sterile water for 
injection. Doses <125 µg were used only in mares known to be in late or prolonged 
diestrus (>10 days post ovulation) or following pregnancy loss, since it was known that 
the dose response rate was highly dependent on the age of the most recent CL. A 
clinical full response to CLO was assumed when within 6 days of treatment the mare 
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developed endometrial oedema and the CL was no longer visible, and when the cervix 
and teasing behaviour were coincident with the oestrous phase. 
 
3.2. Human chorionic gonadotrophin 
A dose of 1500 IU of hCG (Chorulon® Intervet Ltd, Cambridge, UK) was administered 
subcutaneously to induce ovulation in oestrous mares with visible endometrial oedema 
and a follicle ≥35 mm in diameter. 
 
3.3. Deslorelin (I) 
A GnRH agonist was used in the form of subcutaneous implants (Ovuplant® Dechra 
Veterinary Products Ltd, Shrewsbury, UK; 2.1 mg of deslorelin) to induce ovulation in 
oestrous mares with visible endometrial oedema and a follicle of 30 to 35 mm in 
diameter. 
 
3.4. Post-mating treatments (III) 
Mating was by natural cover on the stud farm. Farm staff was in charge of handling the 
stallions and mares. No stallion covered more than 4 mares on a single day. All TB 
mares mated on the stud farm received a routine post-mating treatment during 
veterinary examination which consisted of an intrauterine infusion of antibiotics 
penicillin procaine (6 ml of Depocillin Procaine Penicillin 300 mg/ml, Intervet Ltd., 
Cambridge, UK)  and framycetin (6 ml of Framomycin 15% injection, C-Vet, 
Shrewsbury, UK) in a 12 ml undiluted volume 24 to 48 h post mating in addition to 25 
IU of oxytocin (Oxytocin Leo; Leo Laboratories, Princes Risborough, UK) 
subcutaneously 24 h later.   
4. Clinical diagnosis of the stage of the cycle 
The stage of the cycle at each examination in the majority of mares was ascertained by 
the known day of the previous ovulation. However, in some cases, in which mares were 
brought to the farm or clinic with no reproductive histories, the following criteria were 
used to determine the stage of cycle: 
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4.1. Manual palpation of the cervix 
A manual examination that involved palpating the cervix via the vagina was performed 
for any mare that presented for the first time as a reproductive examination for the 
determination of oestrus. Mares that required pregnancy diagnosis were excluded from 
this examination. A presumptive diagnosis was made according to the tonicity, oedema 
and opening of the cervix. A presumptive diagnosis was further confirmed by 
ultrasonography. 
 
4.2. Ultrasonography 
The visualization of endometrial oedema was often sufficient to diagnose the mare as 
being in oestrus. Confirmation was obtained by imaging the ovaries for large follicles 
and absence of a visible CL or fresh ovulation. When uterine oedema was absent, or 
ultrasound images or palpation of the ovaries did not reveal a CL or fresh ovulation, or 
the vaginal examination had been inconclusive, a teaser stallion was used to assess the 
mare’s behaviour to teasing. All the above mentioned criteria, in addition to frequent 
ultrasound examinations of the ovaries for the follow-up of developing structures were 
successfully used to determine the stage of the cycle in every case.   
 
5. Experimental design 
5.1. Repeatability of follicular diameter and endometrial oedema in individual mares 
(I) 
All 53 mares used in the study were followed for at least 2 consecutive cycles, which 
included transrectal ultrasound examinations at 8 h intervals for at least 24 h prior to 
ovulation. All  mares had one spontaneous cycle in which no hormonal treatment was 
used to induce oestrus or/and ovulation. In the following cycle, the mares were allocated 
to one of the following treatment groups: 
 
- Control group (n = 20): no hormonal treatment was used to induce ovulation in the 
first cycle (spontaneous cycle). 
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- hCG-induced ovulation (n = 14): mares were administered 1500 IU of hCG 
subcutaneously when they were in oestrus and had a follicle ≥35 mm (all follicular 
diameters at the time of hCG injection ranged from 35 to 40 mm). 
 
- CLO-induced oestrus (n = 13): mares were given 125 to 250 µg CLO in dioestrus in 
the presence of a diestrous follicle ≥25 mm. 
 
- Deslorelin-induced ovulation (n = 6): mares were subcutaneously implanted with a 
2.1 mg deslorelin-implant during oestrus at the time the mare had a follicle 30 to 35 
mm in diameter.  
 
Only mares that had single ovulations in consecutive cycles were included in the study. 
It was hypothesized that mares with spontaneous consecutive cycles will ovulate 
follicles of similar diameters.  
 
5.2. Effect of cloprostenol dose and follicular diameter on the interval from treatment 
to ovulation (II) 
Ultrasound examination was performed at intervals ranging from 6 to 24 h (most 
frequently every 8 h) (n = 230 oestrous cycles at the clinic) or every two days (n = 1004 
oestrous cycles on the stud farm). Dioestrous mares were administered one of the 
following doses: 8.75 (n = 174), 12.5 (n = 125), 25 (n = 193), 75 (n = 292), 125 (n = 
187), 250 (n = 122) or 625 (n = 141 oestrous cycles) µg of CLO. The mares used in the 
study were divided into three groups according to the follicular diameter at the time of 
CLO administration: 1) diameters from 28 to 31 mm; 2) diameters from 32 to 35 mm 
and 3) diameters ≥36 mm.  
 
The largest follicle at the time of PGF administration was followed for each mare and 
classified into one of the following categories:  
 
- Regressing: when the diameter of the follicle became smaller or remained static 
and was overridden by the development of a new ovulatory follicle. 
 
- HAF: this type of follicle was regarded as regressing. 
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- Ovulatory: when the dominant follicle at the time of the CLO treatment was 
followed by an ovulation.  
 
For data analysis on the effects of CLO dose rate and follicular diameter on ITO, only 
mares with ovulating follicles were used. Mares that had only a partial response, 
including those that had ovulated during dioestrus, and also those mares that showed no 
clinical response within 6 days of treatment were excluded from the data. The ITOs 
ranged from 1 to 12 days. In general, 250 µg CLO was used in mares 5 to 7 days post-
ovulation, 500 µg <5 days and 125 µg >7 days.  
 
It was hypothesized that mares with larger follicles at the time of CLO treatment will 
have shorter intervals to ovulation than mares with smaller follicles. Furthermore, mares 
treated with higher doses of CLO will have shorter intervals to ovulation than when 
lower doses are used. 
 
5.3. Effect of interval from treatment to ovulation on pregnancy and multiple 
ovulation rate (III) 
Mares were classified into groups according to whether oestrus was induced by CLO or 
occurred spontaneously. Treatment was a single dose of 250 µg of CLO which was 
administered to most mares on day 5 to 7 of the cycle. CLO-treated mares were also 
classified according to the length of the ITO. The groups were classified as follows: 
 
- Group 1: mating after spontaneous return to oestrus (n = 57 mares). 
 
- Group 2: mating in CLO-induced oestrus with ovulations 4 to 7 days post-treatment 
(n = 77 mares). 
 
- Group 3: mating in CLO-induced oestrus with ovulations 8 to 10 days post-
treatment (n = 89 mares). 
 
- Group 4: mating in CLO-induced oestrus with ovulations ≥11 days post-treatment (n 
= 106 mares). 
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According to the results of the pregnancy test on days 12 to 14 post-ovulation, mares 
were classified as either pregnant or non-pregnant. In addition, individuals in each 
group were also classified according to the number of ovulations in each cycle. Thus, 
each mare could have either a single ovulation or MO: the latter being one or more 
ovulations within 2 days of the first ovulation. The number of embryos per ovulation 
was also determined. 
 
5.4. Effect of cloprostenol and human chorionic gonadotrophin on the occurrence of 
haemorrhagic anovulatory follicles (IV, V) 
The incidence of HAF occurrence was determined by the long term analysis of 
reproductive records of 7 mares during their entire reproductive lives (>10 years, 612 
oestrous cycles). The breeds were Irish draught (4 mares), Shire (1 mare), TB (1 mare) 
and Warmblood crossed with Irish draught (1 mare). Furthermore, the effects of CLO, 
age of the mare and season on HAF occurrence were investigated in 2 of the 7 mares 
known to have an intrinsically high HAF incidence (IV). Moreover, the effect of the 
same factors in addition to the effects of hCG were investigated by analysing the 
records of a large population of mares (207 mares, 765 oestrous cycles) over 2 years 
(V). Other parameters such as uterine oedema pattern and length of the oestrous cycle 
obtained from mares with ovulatory or HAF cycles were compared (IV, V). 
 
6. Statistical analyses 
All data were computed using the statistical software Minitab Release 15® (Minitab 
Inc, State College PA, USA). Numerical data were tested for normality using the 
Anderson-Darling test and for equality of variances using Bartlett’s test. Normally 
distributed data were analyzed using parametric tests and data not normally distributed 
were analyzed by non-parametric tests. Significance was set at a level of α = 0.05. 
 
The Paired t-test was used to analyze the effect of induction treatments on preovulatory 
follicular diameter. The strength of agreement (repeatability) between preovulatory 
follicular diameters of two spontaneous (non-induced) consecutive cycles was assessed 
by Pearson’s correlation. The strength of agreement of endometrial oedema pattern 
between non-induced consecutive cycles was estimated by Spearman’s ranked (non-
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parametric) correlation analysis (I), whereas the effect of induction treatment on 
endometrial oedema score at each examination point was tested using the Mann-
Whitney non-parametric test. A general linear model of variance was used to test the 
effect of the CLO dose and follicular diameter on the ITO. Binary logistic regression 
was used to determine the relationship of cause and effect between the dose of CLO, 
follicular diameter and the percentage of regressing follicles (II). Within each follicular 
diameter group, Kruskas-Wallis test was used to analyze the effect of CLO dose on 
ITO. A mixed model with three fixed factors with 3-way interactions (age, season and 
use of CLO) was used to analyze the association of the factors with the occurrence of 
HAFs (IV). The Chi-square test was used to analyze categorical data on the effect of 
CLO on PR and MO rate (III) in addition to test the association of induction treatments 
hCG, CLO and season with the incidence of HAF (V). Moreover, the effects of age and 
follicular diameter at the time of CLO treatment on HAF incidence were analyzed by 
the two- sample t-test (IV, V). Mann-Whitney non-parametric test was used to analyze 
the effect of the CLO dose on the incidence of HAFs (IV).  
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RESULTS 
1. Repeatability of preovulatory follicular diameter (I) 
Mares ovulated consistently from similar preovulatory follicular diameters in two 
consecutive spontaneous cycles. The positive coefficient of the correlation indicated a 
strong level of agreement (r = 0.89) and was significant at P<0.001 (Figure 1). 
Treatment of mares to induce oestrus or ovulation with hCG, CLO or deslorelin reduced 
significantly the preovulatory follicular diameter of the induced cycle (P<0.001, 
P<0.001 and P< 0.01, respectively) (Figure 2). Mean preovulatory follicular diameters 
for each group are shown in Table 1. 
 
2. Repeatability of endometrial oedema pattern  
Mares showed a fair correlation in endometrial oedema patterns during the last 24 h 
before ovulation between consecutive spontaneous cycles (r = 0.71; P<0.01). Mares 
induced with deslorelin or hCG showed similar oedema scores as non-induced mares 
(Figure 3a), the CLO-group showed higher oedema scores than the non-treated mares 
(P<0.05) (Figure 3b). 
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Figure 1. Scatter plot of preovulatory follicular diameters in two consecutive cycles. Each symbol 
represents the preovulatory follicular diameter (mm) for two non-induced (spontaneous) consecutive 
cycles (n = 20). (r = 0.89; P<0.001).  
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Figure 2. Effect of hCG, CLO and deslorelin on preovulatory follicular diameter. The columns represent 
mean follicular diameter ± SE of the mean (whiskers) for each treatment group. Each treatment group 
includes a spontaneous cycle (non-striped columns) and a cycle induced (striped columns) with hCG (n = 
14), CLO (n = 13) or deslorelin (n = 6). For each treatment group both cycles were consecutive. The 
spontaneous group is the average of two non-induced cycles (n = 20). Within columns of same colour, 
asterisk (*) shows significant difference (P<0.01) between spontaneous and induced cycles. 
 
 
Table 1. Mean ± S.E.M. preovulatory follicular diameter in spontaneous (sp) and induced cycles 
Different superscripts (a, b) show significant differences (P<0.01) within groups. Non-induced (n = 20), 
hCG-induced (n = 14), CLO-induced (n = 13) and deslorelin-induced (n = 6). 
 
 
Non-induced hCG CLO deslorelin 
sp sp sp induced sp induced sp induced 
46.03a 46.33a 44.18a 38.82b 47.77a 39.42b 40.92a 34.25b 
± 1.42 ± 1.34 ± 1.22 ± 0.83 ± 2.0 ± 1.77 ± 1.38 ± 0.65 
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Figure 3a. Endometrial oedema score in the preovulatory period. Lines connect mean endometrial oedema 
scores for each examination point (24, 16, 8h prior to ovulation and when ovulation (Ov) was first 
detected). The “spontaneous” line connects mean endometrial oedema scores of all spontaneous cycles 
for all groups (n = 73). 
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Figure 3b. Endometrial oedema score in the preovulatory period in mares with spontaneous cycles and 
induced with CLO. Each line connects mean endometrial oedema scores for each examination point of 
two consecutive cycles for the spontaneous (black lines, n = 20 in each point) and CLO-induced groups 
(red lines, n = 13 in each point). (*) shows significant difference (P<0.05) between examination points of 
consecutive cycles within the same group (CLO-induced versus non-induced). 
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3. Relationship between cloprostenol dose, follicular diameter and interval from 
treatment to ovulation (II) 
There was a negative effect between the dose of CLO (P<0.01) and follicular diameter 
(P<0.01) on the ITO. Regardless of CLO dose, mares with follicular diameters of 28-31, 
32-35 and ≥36 mm had a median interval to ovulation of 5, 4 and 4 days, respectively 
(Figure 4). Within each follicular diameter group, the ITO for CLO dose groups of 8.75, 
12.5, 25, 75 and 125 µg was not statistically different. The largest dose of CLO (625 
µg) resulted in the shortest ITO for each diameter group (median of 4 days, P<0.05; 3 
days, P<0.01; and 2 days, P<0.01 for diameter groups of 28-32, 32-35 and ≥36 mm, 
respectively). The second largest dose (250 µg) induced shorter ITO than smaller doses 
only in the largest follicular diameter group (≥36 mm; P<0.05). The box plot 
distribution of ITO for all groups is shown in Figure 5.  An unexpected finding was that 
CLO dose and follicular diameter at the time of the treatment were associated with an 
increased occurrence of regression of dominant follicles. This association was 
significant at P<0.01 (dose) and P<0.05 (follicular diameter). The larger the follicle at 
CLO treatment, the more likely it was to regress. The larger the dose of CLO, the less 
likely was the follicle to regress (Table 2). The overall incidence of HAFs was 1.9%. 
The CLO doses with highest incidence of HAFs were 250 and 625 µg, 3.9% and 2.1%, 
respectively. Although the incidence was greater when higher doses were used, this 
association was not significant. 
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Figure 4. Effect of follicular diameter on ITO. Groups 28-31 (n = 325), 32-35 (n = 286) and ≥36 mm (n = 
318). The interquartile boxes show the interval (days) from CLO treatment for each follicular diameter 
group to ovulation regardless of CLO dose (P<0.01). The upper line of the box indicates that 75% of the 
observations are less or equal to that interval. The lower line of the box indicates that 25% of the 
observations are less or equal to that interval. The middle line of the box represents the median interval to 
ovulation for each dose group. Upper and lower whiskers extend to the highest and lowest data values 
within the upper and lower limits respectively. Asterisks (*) denote unusually small numbers of 
observations. The median interval to ovulation in group > 36 is 4 days.  
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Figure 5. Box plot distribution of ITO (days) according to CLO dose (µg) and follicular diameter (mm). 
Follicular diameter groups: 28 to 31 mm (n = 325), 32 to 35 mm (n = 286) and ≥36 mm (n = 318). Within 
each follicular diameter group, the median ITO of mares treated with 625 µg of CLO was shorter 
(P<0.05) than in the rest of CLO dose groups. Within the largest follicular diameter group (≥36 mm), the 
median ITO of mares treated with 250 µg of CLO was shorter (P<0.05) than in the rest of lower CLO 
doses but longer than in the 625 µg group (P<0.05). Asterisks (*) indicate unusually small numbers of 
observations. 
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Table 2. Effect of CLO dose and follicular diameter on the ITO and on the fate of the follicle 
 
28-31 mm 32-35 mm >36 mm All follicle diameters CLO 
dose 
µg n ITO 
% 
Regress n ITO 
% 
Regress n ITO 
% 
Regress Total 
% 
Regress 
% 
HAFs 
8.75 54 5a 27. 8 56 4a 44.6 64 4a 34.4 174 35.6 1.1 
12.5 46 5a 21.7 40 4a 27.5 39 4a 33.3 125 27.2 1.6 
25 57 4a 10.5 62 4a 32.3 74 4a 29.7 193 24.9 0.5 
75 86 5a 31.4 99 4a 32.3 107 4a 27.7 292 30.1 2 
125 57 5a 21.1 59 4a 15.3 71 4a 29.6 187 22.4 1.6 
250 47 4a 14.9 30 4a 0.0 45 3b 13.3 122 10.6 4.1 
625 60 4b 11.7 46 3b 19.6 35 2c 20.0 141 16.3 2.1 
Total 407  20.6 392  27.0 435  27.6 1234   
% Regress: percentage of dominant follicles that regressed following CLO treatment. The ITO is 
expressed as the medians (days). Within column of ITO, different superscripts (a, b, c) indicate significant 
difference (P<0.05).  
 
4. Effect of cloprostenol and interval from treatment to ovulation on pregnancy 
and multiple ovulation rates (III) 
PR of CLO-treated mares (62.1%) tended to be lower (P = 0.09) than spontaneously 
ovulating mares (73.7%). Within mares treated with CLO, mares with an ITO of 4 to 7 
days (n = 77) had the lowest pregnancy rate (46.7%; P<0.01) as compared with mares 
with ITO of 8 to 10 (n = 89) and ≥11 days (n = 106) (64.0 and 71.7% respectively).  
MO rate tended to be higher (P = 0.08) in CLO-treated mares (36.4%) than in mares 
with spontaneous return to oestrus (24.6%). CLO-treated mares that had an ITO of 
between 8 to 10 and ≥11 days had higher (P<0.01) MO rates (40.4 and 44.3% 
respectively) than mares with spontaneous oestrus and mares with an ITO of 4 to 7 days 
(24.6 and 20.8% respectively). MO resulted in more multiple pregnancies in mares with 
spontaneous oestrus (71.4%) than in CLO-treated mares (41.4%; P<0.05). The PR, MO 
and multiple pregnancy rates for each group of mares are shown in Table 3. 
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Table 3. Effect of CLO on PR and MO rate 
CLO-induced oestrus: oestrus following administration of 250 µg CLO; PR: pregnancy rate at 12 to 14 
days post-ovulation; Multiple pregnancies: proportion of mares with multiple ovulations that had multiple 
pregnancies. Within each column different superscripts (a, b) indicate significant difference (P<0.05). PR: 
percent of pregnant mares of all mated; MO: percentage of multiple ovulations from all ovulations; 
Multiple pregnancy: percentage of mares with multiple embryonic vesicles from all mares with multiple 
ovulations. 
 
5. Association of seasonal and management factors with the occurrence of 
haemorrhagic anovulatory follicles 
5.1. Long term study of 7 mares (IV) 
A sample of the ultrasonographic characteristics of the development of HAFs is 
depicted in Figure 6. Only 1 out of the 7 mares with a history of repeated HAFs, that 
were studied for over 10 years had no recorded HAF. Four mares had HAF incidences 
between 2.8 and 7.5% and the remaining two had incidences as high as 24.7 and 25.3% 
(Table 4). The recurrence rate after the first (ever occurring) HAF cycle in that same 
year was 0% (mean age at first HAF cycle 6.4 ± 1.3 years). However, the recurrence 
rate of HAF at some oestrous cycle during the lifetime was 100% in the 6 mares that 
had HAFs.  
 
The two mares with the highest incidences (mares 1 and 2) were more likely to have 
HAF cycles after induction with CLO (P<0.01) than during spontaneous cycles (Table 
4). There was a significant association of CLO dose with the incidence of HAF 
development (P<0.01): the CLO dose used in non-HAF cycles averaged 254.5 ± 21.5 
µg compared with 375 ± 35 µg in HAF cycles. The mean largest follicular diameter at 
the time of CLO administration in HAF cycles (15.6 ± 1.4 mm) was not significantly 
smaller than in non-HAF cycles (18.8 ± 1.9 mm). The interval from CLO treatment to 
Group of mare 
CLO-
induced 
oestrus 
ITO (days) PR (%) MO (%) Multiple pregnancy (%) 
1 
(n = 57) no - 73.7
a 24.6a 71.4a 
2 
(n = 77) yes 4-7 46.7
b 20.8a 37.5b 
3 
(n = 89) yes 8-10 64.0
a 40.4b 38.9b 
4 
(n = 106) yes ≥11 71.7
a 44.3b 44.7ab 
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ovulation or the beginning of HAF formation was not different (7.1 ± 0.2 and 7.7 ± 0.2 
days).  
 
There was an effect of season (P<0.01) on HAF incidence. The occurrence of HAFs 
was higher during early (April to July) and late in the ovulatory season (August to 
November) than in the winter months, with incidences of 31, 28.1 and 11.7%, 
respectively (Figure 7). Incidences of HAFs in different age groups were not 
significantly different: 23.5, 25.7 and 26.1% for the young, middle age and old mares, 
respectively (Figure 8). However, mares 1 and 2 had only 1 HAF cycle (2.4% 
incidence) during the first three years of their reproductive lives (41 oestrous cycles 
during the period of age between 2 and 4 years). 
 
The likelihood of having two consecutive HAF cycles was 31.5%. When the cycle 
immediately following a HAF cycle was induced with CLO, the probability increased to 
40%, but without induction, a new HAF cycle developed only in 9% of the times. The 
uterine oedema patterns of HAF cycles without concurrent ovulations (n = 34 HAF 
cycles) were compared with those of non-HAF cycles (n = 30, randomly chosen); no 
significant difference at any observation time between the two types of cycles was 
found. Mares 1 and 2 had a total of 80 HAFs, of which 40% were solitary HAF(s) only 
without any concurrent normal ovulations. In contrast, the remaining 60% occurred 
alongside normal ovulation(s) within the same cycle. Details of different types of HAF 
cycles are shown in Table 5. 
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Table 4. Reproductive data of 7 mares followed for ≥ 10 years 
Breed: ID = Irish Draught; SH = Shire; WB = Warmblood. (*) indicates that the reproductive period 84-90 in mare 3 is 
missing, and therefore the age of the first HAF might not be accurate. Follicular diameter: mean preovulatory follicular 
diameter of all cycles recorded. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mare Breed Years Recorded  
Oestrous 
cycles (n) 
MO rate 
(%) 
Follicular 
diameter 
Age 
at 1st 
HAF 
Overall 
HAF 
occurrence 
(%) 
CLO-
induced 
cycles 
(%) 
HAF 
occurrence 
in CLO-
cycles (%) 
1 
 TB 91-07 162 24.0 33.8 5 25.3 61.1 97.6 
2 
 ID 90-07 158 47.2 34.9 3 24.7 67.7 84.6 
3 
 SH 91-07 53 10.5 52.8 19* 7.5 17 20 
4 
 ID 94-07 81 20.1 39.3 7 7.4 38.3 66.7 
5 
 ID 96-07 71 21.4 46.1 11 2.8 39.4 100 
6 
 
ID x 
WB 98-07 37 2.9 48.5 6 5.4 27 50 
7 
 ID 96-07 50 22.0 44.8 - 0 36 - 
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Figure 6. Ultrasonograph series of the development of a HAF from day 0 (day of expected ovulation) to 
day 2 at approx. 8-h intervals. A: (0 h): follicle fills with echoic specks and acquires irregular shape. B: 8 
h. C: 16 h, granulosa cell layer becomes gradually hyperechoic and thickened and the intrafollicular 
specks increase in numbers and their echogenicity. D: 24 h. E: 32 h, luteinized follicle increases in 
diameter. F: 48 h, intrafollicular contents organize and become static in appearance.  Progesterone levels 
for 0 h (A) = 2.2 ng/ml; 24 h (D) = 4.0 ng/ml and 48 h (F) = 4.3 ng/ml.  
 
 
 
 
A  B 
 C  D 
 E  F 
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Table 5. Different combinations of HAF cycles in the 6 mares that had HAFs (IV)  
Upper values represent the number of cycles with one HAF or more HAFs with one (+ ov) or without 
concurrent ovulation(s). The lower value shows the percentage of cycles from the total in each row.  
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Figure 7. Effect of month on HAF incidence. The values above each column represent the total number of 
oestrous cycles recorded per month over the reproductive lives of mares 1 and 2 (IV). Columns show 
HAF incidence (%) by month. There was a significant effect amongst group of months (different filling 
pattern), Dec-Mar (11.7%) lower than Apr-Jul (31%) and Aug-Nov (28.1%) P<0.01. 
 1HAF 2 HAFs >2 HAFs 1 HAF + 1 ov 
2 HAFs 
+ 1 ov 
1 HAF 
+ 2 ov 
2 HAFs 
+ 2 ov Overall 
Mares 1-2 17 20% 
14 
16% 
3 
4% 
33 
43% 
6 
7.5% 
6 
7.5% 
1 
1.4% 
80 
 
Mares 3-6 8 53 % 
3 
20 % 
0 
0 % 
3 
20 % 
1 
7 % 
0 
0 % 
0 
0 % 
15 
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Figure 8. Effect of age of mare on HAF incidence (IV). Columns represent the percentage of HAF cycles 
for mares 1 and 2 in all oestrous cycles during each year of their reproductive life. The values above of 
each column represent the total number of cycles recorded in each year. The incidence of HAF was not 
statistically different amongst the age groups (different filling pattern).  
 
5.2. Two-year study of a large population of mares (V) 
The overall incidence of HAFs was 5.0% (765 oestrous cycles from 207 mares during 
the two-year period). Cycles induced by CLO alone had a higher incidence of HAFs 
(8.4%) than those induced using both hCG and CLO (7.6%; P>0.05), or hCG alone 
(3.7%; P = 0.08), or in spontaneous cycles (0.8%, P<0.001). Incidence of HAF cycles in 
mares treated only with hCG tended to be (P = 0.054) higher than that of spontaneous 
cycles. The effect of the induction treatment was not significantly different between the 
years. In CLO-induced HAF cycles, the mean interval from the CLO treatment to the 
day of expected ovulation was 6.1 ± 0.5 days, whereas in HAF cycles induced by hCG 
the mean was 2.0 ± 0.4 days. The HAF recurrence rate in a consecutive cycle (n = 26 
cycles) and following year (n = 5 mares) was 4% and 60%, respectively.  
 
The incidence of cycles with solitary HAF(s) was 68% (26 out of 38 HAF cycles), 
whereas the incidence of HAF(s) cycles accompanied by concurrent normal ovulation(s) 
was 32% (12 out of 38). The two spontaneous non-induced HAF cycles had no 
concurrent ovulation(s). The season had no significant effect on HAF incidence. When 
data from both years were pooled together, the incidence of HAF was 2.4, 5.6 and 3.9% 
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for winter, early and late ovulatory season, respectively. HAF incidence per month and 
per year is shown in Table 6. The mean age of the mares that developed HAF cycles 
during the two-years period was 12 ± 1.4 years (range 2 to 26). This was not 
significantly different from mares with no HAF cycles (mean age 10.5 ± 1.5 years; 
range 2 to 20).  
 
The endometrial oedema pattern of HAF cycles without concurrent ovulations was 
compared with those of ovulatory cycles. No significant difference in oedema scores at 
any observation time was found between the two types of cycles. The interval from the 
beginning of HAF development to the next non-induced ovulation was 21.6 ± 1.3 days. 
 
 
Table 6. Effect of type of cycle on HAF incidence    
Year Cycle type Sp CLO hCG CLO + hCG 
HAF 0 10 3 4 
2006 
Non-HAF 124 128 55 38 
HAF 2 12 2 5 
2007 
Non-HAF 123 113 75 71 
Total cycles 249 263 135 118 
HAF cycles 2 22 5 9 2006-07 
HAF 
incidence (%) 0.8
a 8.4b 3.7b* 7.6b 
Sp: spontaneous oestrus non-induced; CLO: oestrus induced with CLO; hCG: spontaneous oestrus and 
ovulation induced with hCG; CLO + hCG: oestrus induced with CLO and ovulation induced with hCG. 
Within row different superscripts (a, b) indicate significant difference (P<0.001) and tendency (a,b*  P = 
0.054). 
 
 
Table 7. Effect of month on HAF incidence during 2006 and 2007 
There was no significant effect of season on the incidence of HAF. Winter (Dec-Mar) 2.5%, early 
ovulatory season (Apr-Jul) 5.6% and late ovulatory season (Aug-Nov) 3.9%.  
 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Total cycles 8 22 41 76 111 157 135 90 62 40 12 11 
HAF cycles 0 1 1 2 6 12 7 4 2 1 2 0 
HAF 
occurrence 
(%) 
0 4.5 2.4 2.6 5.4 7.6 5.2 4.4 3.2 2.5 16.7 0 
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DISCUSSION 
1. Repeatability of follicular and endometrial characteristics in consecutive cycles 
(I) 
1.1. Preovulatory follicular diameter 
Follicular diameter still remains the single criterion that is mostly used by veterinarians 
to decide when to mate a mare despite the known large variation in follicle diameters 
across breeds and individuals (Ginther 1995). In order to overcome the inherent 
inaccuracy of this criterion, some practitioners look back to previous records of 
preovulatory diameters and assume that the mare will ovulate a similar sized follicle as 
in her previous cycle(s).  However, there are no studies in the literature that support this 
approach. Study I showed a good degree of repeatability in follicular diameter between 
consecutive cycles. Although some mares had a discrepancy in diameter of more than 5 
mm (n = 3), most mares ovulated follicles within 3 mm diameter difference between 
their respective consecutive cycles (n = 17). Considering the huge range in preovulatory 
follicular diameters of the mare population (34 to 70 mm) (Ginther 1995) and in the 
present study (ranging from 36 to 59 mm), an existing record of follicular diameters of 
earlier cycles is useful in the prediction of the preovulatory diameter of a given cycle. 
Therefore records can also indicate the optimal breeding time, especially for mares that 
ovulate from unusually small follicles.  
 
This initial observation on the high degree of repeatability of diameters of preovulatory 
follicles between consecutive cycles has since been confirmed by the results of a recent 
controlled study (Jacob et al. 2009). Those authors also showed a significant positive 
correlation for LH and FSH concentrations between consecutive interovulatory intervals 
in individual mares. Interestingly, the oestrous cycle length of two consecutive cycles 
was also highly repeatable.  The similar length in the interval from ovulation to 
follicular deviation, overall inter-oestrus length and LH levels in consecutive cycles 
probably accounts for the repeatability in follicular diameters 3 to 1 days prior to 
ovulation (Jacob et al. 2009). It is important to stress that the degree of repeatability is 
strong only between non-treated spontaneous cycles, that is, in mares returning to 
oestrus and ovulating spontaneously without hormonal induction of oestrus or ovulation 
(PGF, hCG or GnRH).  
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For several years it has been known that the use of hCG has a profound effect on the 
diameter of the preovulatory follicle (Gastal et al. 2006a). When this drug is 
administered to a mare with a growing follicle, the follicular growth immediately stops 
but only if the follicle responds to hCG with ovulation within 48 h. If for some reason 
the follicle does not respond to hCG, it will continue to grow for several days until 
ovulation occurs. This was the case for 3 mares in the present study (I) which had a 
follicular diameters ranging 35 to 40 mm at the time of hCG administration. In spite of 
the hCG administration, these 3 mares ovulated 120 ± 12 h after the hCG treatment, 
reaching preovulatory follicular diameters of more than 50 mm.   
 
The cessation of follicular growth caused by hCG appears to be related to the effect of 
hCG on 17β-oestradiol secretion pattern within the follicle. Following hCG 
administration, follicular growth stops, 17β-oestradiol concentration decreases sharply 
and LH increases in a similar way that is seen in spontaneous non-induced cycles 2 days 
before ovulation (Ginther 2009c). Similarly, deslorelin-implanted mares ovulated 
significantly smaller follicles (34.2 ± 0.6 mm) than those of spontaneously ovulated 
mares (40.9 ± 1.4 mm). The group induced by deslorelin ovulated smaller follicles than 
the administered hCG-group. This is not surprising as these mares were implanted 
purposely when they had small follicles (30-35 mm). Although not critically studied, 
the mechanism by which the GnRH analogue is able to stop follicular growth appears to 
be similar to that observed for hCG.  
 
It was surprising to see the significant effect of CLO on the preovulatory follicular 
diameter despite the relatively long interval from CLO administration to ovulation (6.7 
± 0.7 days). There are reports of an immediate release of gonadotrophins into peripheral 
blood circulation after the administration of PGF (Jöchle et al. 1987; Ginther et al. 
2007a). However, this does not seem to account for the reduction in preovulatory 
follicular diameter in CLO-treated mares since the surge in gonadotrophins is short-
lived (about 4 hours). In addition, the interval between treatment and ovulation for CLO 
was found to be much longer than that observed after induction using other ovulatory 
drugs such as hCG or deslorelin. A subsequent study has found a possible explanation 
for this: following PGF-induced luteolysis, the daily growth rate of newly developing 
follicles is greater, about 0.7 mm a day, than that of follicles in non-induced mares 
(Ginther et al. 2008a). These follicles not only grow faster but also ovulate at smaller 
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diameters, which may indicate a faster follicular maturation rate in PGF-induced cycles. 
These mares had higher LH concentrations for several days from shortly after induced 
luteolysis to well past the point of follicular deviation. 
 
It has long been known that the preovulatory follicular diameter remains constant 
during the last 48-36 h prior to ovulation or even becomes slightly smaller within the 
last 24 h (Koskinen et al. 1989; Ginther et al. 2008a). This information can be useful as 
an aid to estimate the optimal breeding time, when follicles are followed on a daily 
basis. Although not analyzed critically, careful observation of raw data from several 
studies appear to show that preovulatory follicles of PGF-induced cycles do not undergo 
the same cessation of growth during the last two days before ovulation as that observed 
for spontaneous cycles (Gastal et al. 1998; Gastal et al. 2006a; Ginther et al. 2008a). 
The knowledge of this phenomenon in PGF-induced cycles is important, if breeding 
management on the basis of cessation of follicular growth is to be followed. 
 
1.2. Endometrial oedema pattern 
The endometrial oedema pattern can be used to estimate the optimal breeding time in 
frequently examined mares. It follows a typical pattern with the highest oedema scores 
obtained 2 to 3 days prior to ovulation, at which point oedema starts to dissipate as 
ovulation approaches (Hayes et al. 1985; Pelehach et al. 2000). The mechanism by 
which oedema disappears before ovulation seems to be that the increasing amounts of 
preovulatory oestrogens up-regulate the endometrial progesterone receptors thus 
allowing the progesterone to work through these receptors to dissipate oedema prior to 
ovulation (Pelehach et al. 2000). In addition, following hCG administration, or 
spontaneous LH surge, 17β-oestradiol concentration decreases sharply within the 
follicle 2 days before ovulation (Ginther 2009c).  
 
This also accounts for the decrease in endometrial oedema degree observed from 36 h 
prior to ovulation (Gastal et al., 2006b). The preovulatory source of progesterone is 
preovulatory follicular fluid, in which progesterone concentration increases as ovulation 
approaches (Belin et al. 2000). Since endometrial progesterone receptors are up-
regulated by oestrogens, they are able to respond to low amounts of progesterone and 
 66
subsequently dissipate endometrial oedema.The results of the present study showed a 
fair correlation in endometrial oedema patterns between two spontaneous consecutive 
cycles. The reasons for the variation in endometrial oedema pattern within mares and 
how the pattern tends to be consistent in consecutive cycles still needs to be elucidated. 
A possible explanation is that individual variation in oedema scores accounts for 
different steroid concentrations in individual mares, which then remain consistent in 
consecutive cycles.  
 
An interesting observation was that the treatment of mares in consecutive cycles with 
hormones increased oedema scores in the peri-ovulatory period as compared with non-
induced cycles. However, this increase was only significant in the CLO-induced group. 
The mechanism by which these treatments affect endometrial oedema pattern remains 
unknown. A possible explanation could be made about the endometrial progesterone 
receptor levels which might be affected by differences in either steroid concentrations or 
the length of the period under their influence due to effects of treatments for induction 
of oestrus and ovulation.  
 
2. Effect of cloprostenol dose and follicular diameter on interval from treatment to 
ovulation, multiple ovulation and pregnancy rates  
Both CLO and follicular diameter had a negative highly significant correlation on the 
ITO. The distribution of the ITOs against CLO dose and against follicular diameter 
clearly shows the tendency of high CLO doses (≥250 µg) to induce ovulation faster than 
lower doses. Similarly, the larger the follicle diameter is at the time of CLO treatment, 
the shorter is the ITO.  
 
2.1. Follicular diameter and interval from treatment to ovulation (II) 
The negative association between follicular diameter at the time of PGF treatment and 
ITO had been previously shown (Loy et al. 1979; Lofstedt 1986; Samper et al. 1993; 
Bergfelt et al. 2006). In a random population of mares, the average of the ITO is about 9 
days. However, the range of variation may be surprisingly high (1 to 15 days). This 
large variation in the ITO can be due, at least in part, to the difference in follicular 
diameters at the time of PGF-induced luteolysis, which can vary from diameters as little 
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as 10 mm to diameters up to >40 mm. The distribution of follicular diameters on days 5 
to 7 in TB mares has been studied (Newcombe and Cuervo-Arango 2009). 
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Figure 9. Distribution of follicular diameters 5 to 7 days post-ovulation in TB mares. The 147 foaling 
mares were scanned on days 5 to 7 and the diameter of the largest follicle was recorded for each mare 
(adapted from Newcombe and Cuervo-Arango 2009). 
 
 
It is worth noting that the results of this study still showed a great variation in the ITO 
even in mares of the same breed, who had similar follicular diameters at the time of 
CLO treatment and with the same dose. For example, the ITO of mares with follicles of 
28 to 31 mm administered 250 µg of CLO varied from 1 to 8 days. However, it is true, 
that the wide variation for each CLO dose lessens to some extent as the follicular 
diameter becomes larger. Although the correlation between follicle size and ITO is 
significant, there are still some unknown factors that account for the wide variation in 
the ITO. It appears that the time of the induced luteolysis relative to the day of the cycle 
(the previous ovulation day) does not affect the ITO (Bergfelt et al. 2006). Bergfelt and 
co-workers found that the median ITO of mares treated with PGF either on day 3 or 10 
of their cycle did not differ. Other factors, such as time of year or inter-individual 
differences (e.g. in LH concentrations) may account for the rest of the variation in the 
ITO. In addition, the developmental stage of the follicle may be involved: growing 
follicles present at the time of luteolysis are likely to continue growing fast until 
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ovulation, whereas mares with static follicles or follicles that have begun to undergo 
atresia may have longer ITOs or they may never ovulate at all (Ginther 1992). 
 
Logistic regression analysis showed some effect of follicular diameter on the fate of the 
largest follicle at the time of CLO treatment. More large follicles underwent regression 
than did smaller follicles. This positive association between the follicular diameter at 
the time of luteolysis and the percentage of follicles undergoing regression might be 
related to the stage of development of the follicle. Large static follicles or those that 
have begun to undergo atresia are more likely to regress. This relationship, although not 
critically studied in the mare, is widely assumed in cattle, a species that has a much 
shorter follicular phase than the horse and which is known to have 2 to 4 follicular 
waves during dioestrus (Lucy et al. 1992; Fortune 1994).  
 
2.2. Cloprostenol dose and interval from treatment to ovulation (II) 
This study is the first to report a dose dependant effect on the ITO length. Doses as low 
as 8.75 µg of CLO (about 30 times smaller than the recommended luteolytic dose) 
administered in mid to late dioestrous were able to induce full luteolysis with ITOs no 
different to those obtained with CLO doses of 12.5 to 125 µg. The ability of microdoses 
of naturally occurring PGF to induce luteolysis in spite of its much shorter half-life has 
been reported (Handler et al. 2004). In their study the administration of a tenth of the 
luteolytic recommended dose for dinoprost to pony mares on day 7 with a significant 
decrease in progesterone 24 h after PGF treatment in all mares was investigated. 
Recently, it has been shown that not only is the luteolytic dose recommended by most 
manufacturers non-physiological so is the pattern of administration: a non-physiological 
single bolus versus a continuous releasing pattern (Ginther 2009a).  
 
The most striking finding was the significant effect of high CLO doses on advancing the 
ITO. The shortest ITO (2 to 3 days) after treatment with the highest doses (≥250 µg) in 
mares with large follicles (≥36 mm) could account for the greater ability of higher doses 
of PGF analogues to induce the release of gonadotrophins with the subsequent 
beginning of luteinization and rapid ovulation as shown some decades ago (Kiefer et al. 
1979). On the other hand, within the smaller follicular diameter group, larger doses of 
CLO also induced shorter ITO compared to lower doses. In this case the immediate 
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CLO-induced release of gonadotrophins did not seem to account for the advancement of 
ITO. The shortest ITO in the 28 to 31 mm group was 4 days, which seems too long to 
be a direct effect of LH release. As discussed earlier, follicles grow more rapidly and 
ovulations occur from smaller preovulatory follicles after PGF-induced luteolysis. In 
addition, the fall in progesterone during spontaneous luteolysis, after PGF release from 
the endometrium, is much more gradual (Townson et al. 1989) than that of exogenous 
PGF-induced luteolysis (Bergfelt et al. 2006). Although there is no scientific evidence 
to support this, high CLO doses could induce luteolysis faster than lower doses and 
perhaps as a result, caused a sharper decline in progesterone. Not only could the 
declining progesterone pattern be different for different doses but the releasing pattern 
of other hormones such as oestradiol, LH and FSH could also differ. It has been shown 
recently that the effect of a single bolus of 2.5 mg of PGF on the change in oestradiol, 
progesterone, LH and FSH concentrations varied significantly from that seen in mares 
infused intravenously with a much lower dose of PGF (0.1 mg) over 2 h (Ginther et al. 
2009a). Moreover, follicles of mares treated with high doses of CLO (250 and 625 µg) 
are less likely to regress than those of mares treated with lower doses. Similarly, this 
difference in the fate of the follicle could be due to different changes in hormonal 
releasing patterns resultant from varying doses of CLO.  
 
2.3. Interval from treatment to ovulation and multiple ovulation rate after oestrus 
induction with cloprostenol (III) 
In the first half of this decade there was an upsurge of interest in designing a protocol 
for reliably inducing multiple ovulations in mares for embryo transfers (Squires and 
McCue 2007). However, as a result of the lack of correlation between the number of 
ovulations and recovered embryos per cycle, in addition to the closure of horse abattoirs 
in the USA that resulted in the subsequent shortfall in availability of equine FSH, the 
research on superovulation was discontinued. After many years of research on the 
occurrence and physiology of multiple ovulations and on protocols to modify it, no 
reference to the involvement of PGF had been made until recently. During the study of 
interrelationships between follicles and systemic hormones in spontaneous and ablation-
induced follicular waves in pony mares, an anecdotal finding regarding the occurrence 
of multiple ovulations was reported (Ginther et al. 2008a). Mares were either 
administered 10 mg of dinoprost on day 10 of the cycle associated with follicular 
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ablation (>6 mm) or received a placebo (spontaneous group). In the group that 
underwent follicle ablation and PGF-induced luteolysis, more mares 6/21 (28.7%) had 
MO than controls 0/21 (0%).  The same research group designed a subsequent study to 
test the hypothesis on whether the increase in MO rate was the result of PGF-induced 
luteolysis alone or affected by follicular ablation (Ginther and Al-Mamun 2009). Forty-
seven pony mares in each group received 5 mg of dinoprost on day 10 or were left 
untreated. Seventeen percent of PGF-induced mares had a double ovulation compared 
with only 2.6% in spontaneously ovulated mares.  
 
The results of the current field study also showed a higher MO rate for mares treated 
with CLO (36.4%) than those in spontaneous cycles (24.6%) in the absence of follicular 
ablation, but the difference was not significant. However, if data are analyzed taking 
into account the ITO in CLO-treated mares, the effect of PGF on the MO rate becomes 
significant. The MO rate of CLO-treated mares with an ITO ≥8 days was significantly 
higher than that of non-treated mares or those with an ITO ≤7 days. Therefore it seems 
clear that PGF alone and without follicular ablation at the time of luteolysis is able to 
increase the MO rate as long as the mare has not relatively large follicles at the time of 
PGF treatment, which may result in an ITO ≤7 days. This finding is in agreement with 
an earlier field study (Katila 2003). Mares treated with PGF and inseminated 8 or more 
days after treatment had an increased MO rate. Although the ITO was not specifically 
analyzed, the interval from treatment to AI can be assumed to be similar to that of the 
ITO.  
 
The increase in the incidence of MO appears to be related to changes in gonadotrophin 
secretion resultant from an earlier luteolysis. Following PGF-induced luteolysis, 
progesterone falls and the inhibitory effect that progesterone exerts on LH is thus 
removed, allowing LH to rise earlier during follicular development (Ginther et al. 
2008a; Ginther et al. 2008b). The elevated LH during early stages of follicular 
development (before, at and after follicular deviation) may explain the increased 
likelihood of those follicles to develop into HAFs or to contribute to the increased 
occurrence of MO later in the cycle. (Ginther et al. 2008a, 2008b and 2009b). This 
phenomenon may explain why mares with large follicles that are past the point of 
follicular deviation at the time of exogenous luteolysis do not experience a similar 
increased occurrence of MO. 
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The timing of exogenously induced luteolysis in relation to the day of the previous 
ovulation may be involved in the mechanism of enhancing the number of multiple 
ovulations (Bergfelt et al. 2006). In that study, mares administered PGF on day 3 had a 
MO rate of 35% compared with only 6% in mares treated on day 10. On the other hand, 
treatment with CLO on day 6 or 10 of the cycle did not affect the incidence of MO in 
TB mares with respective means of the ITOs of 8.2 and 7.6 days (Samper et al. 1993). 
 
2.4. Effect of cloprostenol and interval from treatment to ovulation on pregnancy rate 
There was a positive correlation between the ITO and PR. As the ITO became longer, 
the PR also increased to reach the highest value in spontaneously ovulated mares. The 
difference in PR amongst groups was only significant between mares with an ITO of 4 
to 7 days and those with an ITO of more than 7 days or spontaneously ovulated mares.  
 
This study has clearly shown a phenomenon that is not new to many practitioners. 
Equine practitioners have had the clinical impression that mares mated and ovulated 
soon after PGF treatment have disappointingly low fertility. This statement has been 
discussed in veterinary conferences and text books (Pycock 2007). However, no 
scientific studies have been designed to test this hypothesis until now. Earlier reports 
did not find a negative effect of administration of PGF to induce oestrus on PR (Samper 
et al. 1993) despite the increase in the MO rate (Katila 2003). Samper et al. (1993) did 
not account for the ITO. However in a study by Katila (2003) the interval from 
treatment to AI was accounted for but not the ITO. Mares inseminated 4 to 11 days after 
PGF treatment had no difference in their PR. The lack of agreement in terms of a 
reduction of PR in PGF-treated mares, between the present study and the earlier reports 
may be explained by the fact that the earlier reports did not account for the ITO. The 
shortest interval from treatment to AI in the study by Katila (2003) was 4 days and it 
could have been even longer until ovulation. In addition, the sample size for each group 
is not given.  
 
Because of a non-physiologically short interval between the luteal phase and mating, the 
failure of cervical relaxation has been speculated as an explanation for low fertility. This 
may lead to increased endometrial inflammation and impaired uterine clearance. In 
contrast to this hypothesis, results of a recent study showed relatively high PR (>70 %) 
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in mares mated and ovulated within 5 days of removal of an intravaginal progesterone 
device (CIDR) after 8 to 12 days of treatment in transitional mares (Cuervo-Arango and 
Clark 2009). However, it is known that the progesterone releasing pattern around the 
end of intravaginal device treatment is not comparable to the abrupt decline in 
progesterone following PGF-induced luteolysis (Handler et al. 2007).  
 
Another possible explanation for the reduced fertility of mares with short ITO is the 
possible impairment of oocytes, which have undergone a prolonged development. Most 
of large dioestrous follicles that are found at the time of PGF treatment, 5 to 7 days 
post-ovulation, originate from a follicular wave initiated during the previous oestrus or 
early dioestrus (Ginther 1992). Dioestrous follicles of 35 to 40 mm may have been 
developing for several days before treatment with PGF. After PGF-luteolysis, these 
follicles may still remain in the ovaries for another 4 to 7 days before ovulation. In some 
cases the total development time for these follicles from follicular emergence is 
therefore much longer than that of ovulatory follicles, which originated from the 
primary follicular wave just before either spontaneous or induced luteolysis.  
 
In a recent study (Cuervo-Arango and Clark 2009), the follicular development of 
transitional TB mares in a stud farm in Australia was analyzed. The time interval for 
transitional follicles to proceed from a diameter of 35 mm to ovulation took more than 
one day, which was significantly longer in mares that did not conceive compared to 
mares that became pregnant after the first ovulation of the year. The follicular phase 
preceding the first ovulation of the year is known to be relatively long for some mares 
(Ginther 1990). 
 
The relationship between follicular dynamics and fertility has been thoroughly studied 
in cattle. The cow can have 2, 3 or 4 follicular waves before ovulation. Ovulatory 
follicles of cows with two follicular waves are older (longer developmental time) than 
those of cows with three follicular waves. Interestingly, several studies have shown 
lower fertility in two follicular-wave cows compared with three follicular-wave cows 
(Ahmad et al 1997; Townson et al. 2002; Bleach et al. 2004). A stronger association 
was found between fertility and the length of the ovulatory follicle lifespan or the 
duration of physiological dominance than between fertility and the number of follicular 
waves (Bleach et al. 2004; Wolfenson et al. 2004). In one study (Bleach et al. 2004), the 
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interval from the emergence of the ovulatory follicle to oestrus was about 1 day shorter 
in cows diagnosed pregnant compared with cows diagnosed as non-pregnant (7.8 ± 0.2 
days versus 8.6 ± 0.2 days, respectively; P<0.01). In a study comparing the fertility of 
spontaneous and CLO-induced cows, the PR was not different between the groups, but 
again the ITO was not taken into account (Cairoli et al. 2006).  
 
Further research in horses is needed to elucidate whether the reduced fertility in mares 
with short ITOs is due to oocyte quality, persistent-mating induced endometritis or to a 
combination of both. Nevertheless, having reviewed the known literature available on 
the same subject for equines and other domestic species it seems more logical to 
consider the oocyte quality as the main reason.  
 
2.5. Effect of cloprostenol and interval from treatment to ovulation on multiple 
pregnancy rate (III) 
The multiple pregnancy rate of spontaneously ovulated mares in this study (71. 4%) is 
in agreement with previous studies (69% in Bergfelt and Ginther 1988). In contrast, 
CLO-treated mares with ITO <8 days and MO had significantly fewer multiple 
pregnancies (37.5 and 38.9% for ITOs of 4 to 7 and 8 to 10 days, respectively) than 
mares with spontaneous cycles. It seems that the reduction in the number of embryos 
per ovulation is related to the observed overall lower pregnancy rates in mares with 
short ITOs. However, the reduced number of embryos per ovulation cannot be 
attributed entirely to the prolonged follicular development or increased uterine 
inflammation, since all CLO-treated groups had lower numbers of embryos per 
ovulation regardless of their ITO.  
 
2.6. Clinical relevance of the effect of cloprostenol on luteolysis, interval from 
treatment to ovulation and pregnancy rate 
On several occasions, it is useful for the practitioner to know the clinical outcomes, 
which are likely to occur after the use of CLO.  
The first item is to be aware of the luteolytic effect of very small doses of CLO without 
differences in the ITO as long as the CL age is known, because smaller doses are 
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effective only in mid or late dioestrous mares. The small doses are more physiological 
and also save money because of the smaller amounts of drug used.  
 
Secondly, in some cases, it is important to control the time of ovulation regardless of the 
effect on fertility, especially in recipient mares in embryo transfer programmes. Higher 
doses of CLO, even when administered early in dioestrus will induce shorter ITOs, 
which then can advance the ovulation of the recipient mare and aid with 
synchronization, if needed. 
 
Third, knowing the negative impact that a short ITO has on fertility is most important 
for the practitioner. Therefore it is necessary to examine the ovaries of a mare presented 
for treatment with PGF. If a large follicle is present, the mare is likely to have a short 
ITO, which makes it a reasonable option to miss the ovulation and mating. In such a 
case the practitioner can consider different possibilities, such as to leave the mare 
untreated and wait for the spontaneous return to oestrus. Different factors will influence 
this decision which, are not within the scope of this discussion. However, being aware 
of the effects of CLO and ITO on fertility and follicular dynamics can provide the 
practitioner with enhanced knowledge on how to manage these situations optimally.  
 
3. Haemorrhagic anovulatory follicles (IV, V) 
The expected incidence of HAFs in any given year in a large population of mares 
appears to be around 5%. In study V, the total incidence of HAF cycles in the period 
recorded was 4.9% (38 / 765 oestrous cycles from 207 mares). In the long term study of 
7 mares (IV), the overall incidence was 15.4% (94 / 612 oestrus cycles from 7 mares). 
The 15.4% incidence is 3-fold higher than that expected for a large population of mares. 
The high incidence of HAFs seen in study IV, was skewed by the data of 2 of the 7 
mares with the longest period recorded (17 years, 320 oestrous cycles), which had a 
HAF incidence of 25% (80 / 320) compared with the incidence of 4.8% in the other 5 
mares studied (14 / 292).  
 
The approximately 4 to 5 % incidence found in the current studies is in agreement with 
the results of previous studies that also used a large sample size, e.g. the 4.7% reported 
by Ginther and Pierson (1989). On the other hand, the 8.2% from 721 mares reported by 
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McCue and Squires (2002) is substantially higher than the average. However, this large 
retrospective study included all anovulatory follicles including those without 
luteinization of the follicular wall.  
 
Studies in which low numbers of mares were followed with a known previous history of 
increased HAF development reported higher incidences, for example 54% of all 
oestrous cycles from only 6 pony mares as compared with 0% in 7 mares without 
previous history of HAFs (Ginther et al. 2006).  
 
In conclusion, it appears that in the majority of mares the incidence for HAFs is 4 to 5 
%, whereas some so called “repeater mares” have an intrinsically high incidence of 
HAF development. These mares tend to have several HAF cycles during the same year 
(Ginther et al., 2006a) and during their entire reproductive life (also in mares 1 and 2 of 
study IV). 
 
3.1. Factors associated with the development of haemorrhagic anovulatory follicles 
(IV, V) 
The ovulatory failure of follicles of cyclic mares in the form of haemorrhage and 
luteinization without follicular collapse is a subtle but distinct cause of infertility in 
mares. The research interest on this anovulatory condition has increased during the 
recent years. Between the design, completion and publication of these two studies (IV, 
V), in this dissertation new research has been carried out on the pathogenic mechanisms 
of the development of HAFs, which has helped greatly to understand the scientific 
reasons of the nature of the main findings resultant from these two studies. 
 
Effect of age of mare 
There was no significant effect of age on HAF incidence in mares 1 and 2 during the 
long term study (IV). Nevertheless, there appeared to be a protective effect against HAF 
development during the youngest age as only one HAF in mares 1 and 2 over the 41 
oestrous cycles at the age of 2 to 4 years occurred. In the large population of mares (V), 
the mean age of mares with HAF cycles was not statistically different from that of 
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mares with non-HAF cycles. Moreover, the age of the mares with HAF cycles varied 
from 2 to 26. 
 
In contrast, McCue and Squires (2002) found a significant association between 
increased age and HAF occurrence 4.4% in mares aged 6 to 10 years compared with 
13% for mares aged 16 to 20. However, there is not information on other age groups 
e.g. 10 to 16 or >20 years in their study. In addition, the mean age of mares with HAF 
cycles had a large standard deviation (15.4 ± 5.4). This indicates that this condition 
occurs across a great range of ages.   
 
Seasonal effect 
 Since the first reference to this type of follicles, it has been believed that their 
occurrence was higher during the autumn (Burkhardt 1948; Knudsen and Weiert 1961). 
More recent reports also found this association, 5% from March to May compared with 
23% from September to October (Gastal et al. 1998). However, the mares were not 
followed during the summer months and therefore no comparison between the seasons 
was possible.  
 
In both studies (IV, V), the highest incidence of HAFs was observed during the early 
ovulatory season (April to July) followed by the late ovulatory season (August to 
November) whereas the HAF incidence remained lowest during winter (December to 
March). The association was only significant in the long term study (IV), which was 
probably due to the larger numbers of HAF cycles analyzed. 
 
A possible explanation for the seasonal distribution, and especially for the low 
incidence during winter and early spring months, could be because of the lower LH 
concentration in peripheral circulation due to changes in the photoperiod. Recent 
hormonal controlled studies have clearly shown a link between experimentally 
increased LH concentration during early stages of follicular development and the 
occurrence of HAFs (Ginther et al. 2008b).  Even in spontaneous previous ovulatory 
cycles, mares with subsequent HAFs had increased LH concentrations.  The daily mean 
LH concentration is minimal during the winter months, begins a gradual increase in 
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April to peak concentration in July and decreases again gradually through the autumn 
months (Turner et al. 1979). 
 
Use of cloprostenol 
The use of CLO to induce oestrus was significantly associated with an increased 
incidence of HAF in both studies. CLO was the single factor most associated with the 
development of HAFs. CLO-treated mares were about 10 times more likely to develop a 
HAF than non-treated mares as 87.5% of HAF cycles of the two “repeater mares” (IV) 
were formed following CLO-induced luteolysis. Two contemporary studies found the 
same association between the use of PGF (dinoprost) to induce luteolysis and HAF 
occurrence. In the first study 0 and 24% of spontaneous and PGF-induced cycles 
developed HAF, respectively (Ginther et al. 2008a). In their other study the same group 
reported that 20% of PGF-induced cycles developed HAFs compared with 2% in the 
previous spontaneous cycles (Ginther et al. 2008b). In the same two studies, in addition 
to being induced with PGF, the treated mares had all follicles >6 mm ablated at the time 
of PGF treatment. 
 
When PGF-induced luteolysis occurs, progesterone concentration falls rapidly. This fall 
in progesterone allows LH to rise earlier during the beginning of follicular development 
and reach higher LH concentrations before follicular deviation. The LH concentrations 
in the induced groups in the two studies were higher than in the spontaneous group from 
7 to 2 days before deviation, after which it reached a plateau. LH continued to be higher 
on days 3 and 2 before ovulation but not thereafter. 
 
In the current study the follicles were not ablated and although the CLO-induced cycles 
were more likely to develop HAFs, the difference in the incidence between spontaneous 
and induced cycles was not as high. Perhaps follicular ablation at the time of luteolysis 
exerts a synergistic effect on the later occurrence of HAFs as all follicles emerge from a 
new developing wave while LH is already high. A subsequent study from Ginther and 
Al-Mamun (2009) also found an association between the use of PGF and the 
development of HAFs without previous follicular ablation. Similarly, the difference in 
the incidences of HAFs between spontaneous (2.6%) and induced cycles (12.8%) was 
not as marked.  
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An interesting finding in study IV was the association between HAF formation and the 
use of high doses of CLO. In our practice, as stated previously, higher doses of CLO 
(>500 µg) are administered early in dioestrus at 3 to 4 days post-ovulation to cause full 
luteolysis compared with lower doses (125 to 250 µg) later in the cycle. Although not 
analyzed critically, this correlation between higher doses and higher incidence of HAF 
could be due to the fact that by inducing luteolysis earlier in dioestrus on day 3 to 4, the 
subsequent rise in LH occurs at earlier stages of follicular wave development. In 
contrast, luteolysis induced later in the cycle occurs when follicle development is at a 
more advanced stage.  
 
In study II, in which more than thousand CLO-induced cycles were followed, the 
overall incidence of HAF cycles was relatively low (1.7%) comparable to that of 
spontaneous cycles. It must be stressed that all cycles had a follicle ≥28 mm at the time 
of CLO administration. At that diameter the follicle has already passed the point of 
follicular deviation diameter of 22.5 reported by Ginther (2000) at which the LH 
concentration appears to be critical for the future development of the follicle into a HAF 
(Ginther et al. 2008a and 2008b).  
 
Use of human chorionic gonadotrophin (V) 
The effect of hCG on HAF incidence is not completely clear. Mares treated with hCG 
tended to be more likely to develop HAFs than during spontaneous cycles (V). 
Although the difference approached significance, the number of HAF cycles was too 
small to investigate any other risk factors related to hCG administration regime. 
However, it is true that studies reporting HAFs had often used hCG to induce ovulation 
(Carnevale et al. 1989; Ginther 1992). In addition, Lefranc and Allen (2003) reported an 
association between the use of hCG to induce ovulation and an increased occurrence of 
HAFs. However these mares were also treated with PGF to advance the onset of 
oestrus, a confounding factor which was not taken as relevant in the analysis of their 
data.  
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Multiple ovulators (IV) 
It is worth noting that the mares with the highest HAF incidence (mares 1 and 2) also 
had the two highest MO rates. These mares often had triple (5%) and double (35%) 
ovulations and when a follicle(s) haemorrhaged, in the majority of cases these were 
accompanied by one or two normal ovulations. The increase in the number of follicles 
passed the point of follicular deviation in HAF cycles was significantly higher in the 
“repeater mares” than in mares with lower HAF occurrence (IV). Perhaps these mares 
had an intrinsically higher gonadotrophin circulating concentration in early stages of 
follicular development. Intrinsic high LH levels during spontaneous cycles have been 
reported in mares prone to develop HAFs (Ginther et al. 2008b). 
 
3.2. Clinical characteristics of mares with haemorrhagic anovulatory follicles (IV, V) 
The ultasonographic characteristics of HAF development have been discussed in 
previous sections. A particular variation in the ultrasound appearance of some HAFs of 
mares 1 and 2 was observed (IV). There was a partial loss of follicular fluid resulting in 
a decrease of HAF diameter but its appearance was not similar to that of a collapsed 
follicle. This observation has been confirmed and reported elsewhere (Ginther et al. 
2007b; Cuervo-Arango and Newcombe 2009). The clinical relevance of this atypical 
appearance of HAFs is unknown. It seems that a partially collapsed HAF does not 
release the oocyte as they do in typical HAF cycles. No pregnancy was obtained after 
several matings of mares with solitary partially collapsed HAFs. In addition, the luteal 
phase length of cycles with this type of follicle was not different from those with typical 
HAFs or normal ovulations (Cuervo-Arango and Newcombe 2009). 
 
Endometrial oedema pattern of all HAF cycles analyzed did not differ from those of 
spontaneous cycles, which is a finding that is in agreement with those of previous 
studies (Ginther et al. 2007b). It seems that the ability of luteal cells of a HAF to 
produce progesterone and to respond to endogenous release of PGF is no different from 
that associated with a CL. In addition, no differences were found in progesterone 
concentrations of the normal ovulatory cycles and HAF cycles (Ginther et al. 2007b). 
Furthermore, women with a comparable anovulatory condition (luteinized unruptured 
follicle syndrome) have successfully being used as recipients in embryo transfers (Wang 
et al. 2008). 
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In all HAF cycles analyzed in the current study, several presentations were observed. 
One, two or three HAFs alone or one or more HAFs in combination with one or more 
ovulations were noted. Mares 1 and 2 (IV), which had higher incidences of HAF cycles, 
were more likely to have HAFs accompanied by normal ovulations than mares who had 
lower HAF incidences. This observation seems to reflect the higher ovarian activity in 
these two mares in terms of the number of follicles and multiple ovulations / HAF. The 
clinical relevance of this phenomenon is that a mare with a HAF cycle could become 
pregnant as long as the HAF is accompanied by a normal concurrent ovulation.  
 
A distinct characteristic of this condition is that it tends to recur. The recurrence rate is 
much higher in mares who have high HAF incidences in which more than one HAF 
cycle in the same season is typical such mares 1 and 2 (IV). In contrast, mares that had 
occasional HAF cycles in one season did not usually repeat it in the consecutive cycle 
within the same season. However, they did so in subsequent years as the HAF 
recurrence rate in a consecutive cycle and following year in mares with occasional 
HAFs was 4% and 60%, respectively (V).   
 
3.3. Possible mechanisms of ovulatory failure 
From the results of this study and others (Ginther et al. 2008a and 2008b), it can be 
ascertained that the use of PGF or its analogues to induce oestrus is associated with an 
increased likelihood of developing HAFs. Ginther et al. (2008b) found that LH 
constantly appeared to be increased in HAF cycles from the early stages of follicular 
development compared with non-HAF cycles. Whether elevated LH is the full cause of 
this anovulatory condition or only parallels the effect of other undetected reasons is not 
fully understood. Researchers of the luteinized unruptured follicle syndrome in humans 
have hypothesized that the LH surge could interfere with intra-follicular metabolism of 
prostanoids and proteolytic enzymes when it occurs during the development of 
immature follicles (Coulam et al. 1982). Prostanoids and proteolytic enzymes also are 
necessary for the process of follicular collapse and ovulation in the horse (Sirois and 
Dore 1997) and in other domestic species (Armstrong and Grinwich 1972; Salhab et al. 
2003). It seems clear that the insulting effect derived from PGF luteolysis is a slow 
process since the interval from PGF administration to the beginning of the haemorrhage 
is approximately 6 to 7 days.  
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A histological study on the follicular walls of HAFs of mares has shown some 
differences in the expected availability of VEGF-A (vascular endothelial growth factor-
A) through a reduced expression of Flk-1 (foetal liver kinase-1) in the wall of HAFs 
compared with preovulatory normal follicles (Ellenberger et al. 2009). The same 
authors hypothesized that there could be a link between the reduction in pro-angiogenic 
factors in HAFs and the reduced activity of some enzymes involved in the remodelling 
of tissue necessary for ovulation. Unfortunately, it was not possible to clarify whether 
these changes in the follicle are the cause of ovulatory failure or just the consequence of 
the developing HAF.  
 
In contrast, colour-Doppler assessment of the follicular mural blood flow one day 
before the beginning of haemorrhage / ovulation revealed a greater percentage of 
follicle wall with a colour-Doppler signal in those follicles destined to form HAF than 
in normal follicles before ovulation (Ginther et al. 2007b). This finding indicates a good 
or even greater vascularisation of the follicular wall in HAFs. The area of greater 
vascularisation in HAFs coincided with the apical part of the follicle where wall 
collapse is normally expected. Nonetheless, it still cannot be ascertained whether these 
changes in follicular wall vascularisation before haemorrhage into the dominant follicle 
are the cause or just the consequence of HAF development.  
 
It is worth stressing that after normal follicle evacuation and ovulation, some CH 
develop a central blood clot or lacuna, which in the initial stages of formation is just 
fluid (apparently blood), resembling a HAF before organization of its contents. The 
equine follicular fluid is rich in heparin-like anticoagulant (Stangroom and Weevers 
1962), which retards the clotting of the fluid in both HAFs and normal CHs that refill 
with blood after ovulation. Whether the early CL forms a central blood clot or remains 
as a solid structure appears to be random, since no functional differences between both 
types of CLs were found (Pierson and Ginther 1985b; Townson et al. 1989). The only 
apparent difference between the CH that develops a central lacuna and the luteinized 
HAF is that the HAF never completely collapsed (Ginther et al. 2007b). A similar 
pattern of colour-Doppler ultrasonography of the apical part of the follicle in HAFs was 
observed in ovulatory follicles with a prolonged antral evacuation for more than 3 hours 
during ovulation and septation of the evacuating antrum (Ginther et al. 2007c). 
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3.4. Clinical relevance of haemorrhagic anovulatory follicles and conclusions  
There is little the veterinarian can do after detecting a follicle, which develops 
haemorrhage and subsequent luteinization in mares that have already been mated but 
make arrangements for the next cycle to breed again. It is important to bear in mind that 
some follicles before undergoing follicular collapse during the ovulatory process can 
look exactly like a follicle about to haemorrhage. However, unlike the HAF, the 
rupturing follicle will collapse completely giving the appearance of a hypoechoic solid 
area for at least 12 to 15 h, after which it may fill quickly with blood to resemble a HAF 
in its early stages (Newcombe 1996 and 1997b; Ginther et al. 2007b). In addition, a 
HAF in its early stages of development may remain with a heavy snowy-like 
appearance of echoic particles floating in the follicular fluid for only 12 to 24 h before 
they organize to resemble a CH with a central clot. It is therefore important for this 
purpose to examine mares at least once a day or more frequently if possible, to avoid 
mistaking a normal ovulation / CH for a HAF. 
 
 Assuming that the mare cannot conceive following haemorrhage into a single 
preovulatory follicle, most practitioners would try to induce the following oestrus with 
PGF or its analogues. On the basis of the current results, and especially, when the mare 
is known to have high percentage of HAFs cycles, the next cycle preferably should not 
be induced. It is worth highlighting that mares 1 and 2 (IV) were more than 4 times 
more likely to develop consecutively a new HAF after CLO induction treatment than 
after a spontaneous return to oestrus. Nonetheless, these two mares had acceptable 
fertility in non-HAF cycles and HAF cycles with concurrent normal ovulations. Thus it 
is possible to obtain pregnancies from this type of mare as long as they have an 
ovulation from a ruptured follicle.  
 
 In conclusion, in studies IV and V some useful data have been provided for the 
practitioner in understanding this anovulatory condition in the mare. Moreover, new 
insights for prospective researchers involving hormonal studies to elucidate the 
proposed effect of PGF on the pathogenesis of HAF development have been indicated.   
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CONCLUSIONS 
 
1. The diameter of the preovulatory follicle of individual mares in two consecutive 
spontaneous cycles is highly correlated. Hormonal treatments administering CLO, 
hCG and GnRH agonists significantly reduce the preovulatory follicular diameter in 
the induced cycle. The endometrial oedema pattern during the peri-ovulatory period 
in the same mare is correlated for two consecutive spontaneous cycles. Treatment 
with CLO to induce oestrus will cause stronger endometrial oedema intensity than 
in non-treated cycles. 
 
2. The interval from exogenously induced luteolysis to ovulation is affected by the 
CLO dose and the follicular diameter at the time of the treatment. The larger the 
dose of CLO and the greater the follicular diameter, the shorter the ITO. The 
negative association between CLO dose and ITO is only apparent when 250 µg or 
larger doses are used. The fate of the dominant follicle at the time of CLO treatment 
is affected by the dose of CLO and follicular diameter. The larger the dose of CLO 
and the smaller the follicular diameter, the less likely is the follicle to regress. 
 
3. The MO rate of TB mares is increased after the induction of oestrus with CLO when 
the ITO is longer than 7 days. The PR of CLO treated TB mares with ITOs of 4 to 7 
days is significantly lower than that of non-treated spontaneous cycles or in those 
with an ITO longer than 7 days. 
 
4. There is a significant association between the development of HAFs and the use of 
CLO to induce oestrus. The incidence of HAFs is not affected by the age of the 
mare. However, there is a protective effect during the first few years of age. The 
lowest incidences of HAFs occur during the winter and early spring months. 
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